2011
Marco Ladetto, Federica de Marco, Fabio Benedetti, Umberto Vitolo, Caterina Patti, Alessandro Rambaldi, Anna Marina Liberati, Maurizio Musso, Alessandro Pulsoni, Attilio Olivieri, Enzo Pavone, Enrico Pogliani, Delia Rota Scalabrini, Andrea Gallamini, Vincenzo Callea, Irene Ricca, Mario Boccadoro, Ignazio Majolino, Paolo Corradini, Alessandro M. Gianni, and Corrado Tarella
Clinical and Molecular Results of the Multicenter Randomized GITMO-IIL Trial in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Rituximab-Supplemented High-Dose Sequential Chemotherapy (R-HDS) Is Superior to CHOP-R in Molecular Remissions
Rate, EFS and PFS .
American Society of Hematology 53nd Annual Meeting and Exposion, December 10-13, 2011, San Diego, CA
Abstract #325 appears in Blood, Volume 118, issue 21, November 18, 2011
U. Vitolo, M. Ladetto, C. Boccomini, A. Evangelista, E. Gamba, E. Russo, A. Tucci, A. Chiarenza, A. Pinto, A. De Renzo, F. Zaja, A. Gallamini, A. Bari, I. Alvarez, E. Bernocco, M. Petrini, G. Parvis, B. Puccini, P. Corradini, T. Perrone, S. Supekar, A. Chiappella, B. Botto, B. Mantoan, F. De Angelis, L. Balidini and G. Rossi.
Brief Chemoimmunotherapy R-FND with Rituximab Consolidation Followed by Randomization Between Rituximab Maintenance Vs. Observation As First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Final Results of a Prospective Randomized Trial by Italian Lymphoma Foundation (FIL)
American Society of Hematology 53nd Annual Meeting and Exposion, December 10-13, 2011, San Diego, CA
Abstract #777 appears in Blood, Volume 118, issue 21, November 18, 2011
A. Chiappella, A. Castellino, M. G. Cabras, A. M. Liberati, A. Evangelista, C. Bottelli, F. Salvi, A. Rossi, V. Pavone, M. Nicolosi, G. Parvis, A. Tonso, F. Rossini, C. Pecoraro, D. R. Scalabrini, S. Luminari, P. De Masi, S. Perticone, N. Cascavilla, R. Freilone and U. Vitolo.
Prolonged Survival with Low Incidence of CNS Relapse and Late Toxicities in a Retrospective Series of 278 Young Patients with High-Risk (aa-IPI 2-3) Diffuse Large B-Cell Lymphoma Treated with Intensified Chemotherapy with or without Rituximab at Diagnosis.
American Society of Hematology 53nd Annual Meeting and Exposion, December 10-13, 2011, San Diego, CA
Abstract #1606 appears in Blood, Volume 118, issue 21, November 18, 2011
C. Frairia, C. Ciochetto, E. Audisio, G. Benevolo, B. Botto, A. Chiappella, M. Nicolosi, L. Orsucci, C. Percoraro, P. Pregno, F. Marmont and U. Vitolo.
Rituximab Plus Dose Intense Rapid-Cycling Chemotherapy with Intratecal CNS Prophylaxis in Patients with Burkitt Lymphoma (BL) and Intermediate Unclassifiable Diffulse Large B-Cell Lymphoma/BL: Single Institution Experience.
American Society of Hematology 53nd Annual Meeting and Exposion, December 10-13, 2011, San Diego, CA
Abstract #1631 appears in Blood, Volume 118, issue 21, November 18, 2011
S. Luminari, A. Versari, M. Quaresima, L. Arcaini, C. Rusconi, A. Gallamini, P. L. Zinzani, S. Franceschetti, C. Boccomini, A. JM Ferreri, M. Spina, A. D’Arco, F. Di Raimondo, A.M. Carella, M. Balzarotti, S. Aversa, V. Callea, P. Musto, G. Pinotti, R. Freilone, R. Centurioni, F. Morabito, G. Bertoldero, A. Levis, L. Rigacci, T. Lucilla, A. Pulsoni and M. Federico.
Role of FDG-PET As Prognostic Indicator in Patients with Follicular Lymphoma (FL) After Immunochemotherapy Induction. A Retrospective Study From the Fondazione Italiana Linfomi.
American Society of Hematology 53nd Annual Meeting and Exposion, December 10-13, 2011, San Diego, CA
Abstract #2636 appears in Blood, Volume 118, issue 21, November 18, 2011
S. Luminari, Q. Micol, V. Annibale, L. Arcaini, C. Rusconi, A. Gallamini, F. Merli, M. Spina, A. J.M. Ferreri, P. L. Zinzani, B. Botto, G. Gaidano, A. D’Arco, F. Di Raimondo, A. M. Carella, S. Aversa, C. Stelitano, P. Musto, G. Pinotti, R. Freilone, R. Centurioni, F. Morabito, G. Bertoldero, M. F. Martelli, S. Hohaus, M. Dell’Olio, C. Petti, A. Santoro and M. Federico.
The Use of FDG-PET in the Initial Staging of Patients with Follicular Lymphoma (FL). A retrospective Study From the Fondazione Italiana Linfomi.
American Society of Hematology 53nd Annual Meeting and Exposion, December 10-13, 2011, San Diego, CA
Abstract #2651 appears in Blood, Volume 118, issue 21, November 18, 2011
B. Botto, C. Ciochetto, M. Bellò, R. Passera, G. Bevolo, C. Boccomini, A. Chiappella, R. Freilone, F. Giunta, M. Nicolosi, E. Orlandi, L. Orsucci, C. Pecoraro, P. Pregno, A. Tonso, G. Bisi and U. Vitolo.
Radioimmunotherapy (RIT) with 90-yttrium Zevalin Followed by BEAM Conditioning Regimen (Z-BEAM) and Autologus Stem Cell Transplantation (ASCT) for the Treatment of High Risk Relapsed/Resistant Non Hodgkin’s Lymphoma (NHL).
American Society of Hematology 53nd Annual Meeting and Exposion, December 10-13, 2011, San Diego, CA
Abstract #3107 appears in Blood, Volume 118, issue 21, November 18, 2011
U. Vitolo, A. Chiappella, E. Brusamolino, E. Angelucci, M. Balzarotti, A. M. Carella, G. Ciccone, G. Gaidano, F. Merli, F. Pane, V. Pavone, G. Rossi, L. Rigacci, C. Stelitano, F. Zaja, M. Martelli.
A randomized multicentre phase III study for first line treatment of young patients with high risk (AAIPI 2-3) diffuse large B-cell lymphoma (DLBCL): rituximab (R) plus dose- dense chemotherapy CHOP 14 / MEGACHOP 14 with or without intensified high-dose chemotherapy (HDC) and autologus stem cell transplantation (ASCT). Results of DLCL04 trial of Italian Lymphoma Foundation (FIL).
11th International Conference on Malignant Lymphoma – Lugano, Switzerland, 15-18 June 2011
Annals of Oncology – Vol. 19, Supplement 4, 2011; Abstract #072
M. Federico, S. Luminari, A. Dondi, G. Rossi, C. Boccomini, F. Di Raimondo, L. Rigacci, A. M. Carella, A. Pulsoni, F. Merli, L. Arcaini, L. Marcheselli, M. Brugiatelli, U. Vitolo.
R-CVP vs R-CHOP vs R-FM for the initial treatment of patients with advanced stage follicular lymphoma. Preliminary results of FOLL05 IIL trial.
11th International Conference on Malignant Lymphoma – Lugano, Switzerland, 15-18 June 2011
Annals of Oncology – Vol. 19, Supplement 4, 2011; Abstract #135
L. Arcaini, D. Vallisa, M. Merli, V. Ferretti, A. Ferrario, A. J. Ferreri, A. Chiappella, A. Ambrosetti, A. Tucci, C. Rusconi, C. Visco, M. Spina, G. Cabra, S. Luminari, S. Rattotti, A. Pulsoni.
Hematological response to antiviral treatment in 94 patients with indolent B-cell lymphomas associated with hepatitis C virus infection: A study of the FONDAZIONE ITALIANA LINFOMI (FIL).
11th International Conference on Malignant Lymphoma – Lugano, Switzerland, 15-18 June 2011
Annals of Oncology – Vol. 19, Supplement 4, 2011; Abstract #138
M. Balzarotti, E. Brusamolino, S. Massidda, A. Pulsoni, A. M. Carella, U. Vitolo, M. Spina, F. Merli, A. Levis, A. Re, C. Rusconi, C. Stelitano, N. Cascavilla, G. Gaidano, P. L. Zinzani, A. Santoro.
IGEV vs IGEV+BORTEZOMB (VELCADE-TM) before high-dose consolidation therapy followed by autologus stem cell transplantation (ASCT) in relapsed or refractory Hodgkin Lymphoma (HL): A randomized phase II trial of the FONDAZIONE ITALIANA LINFOMI (FIL)
11th International Conference on Malignant Lymphoma – Lugano, Switzerland, 15-18 June 2011
Annals of Oncology – Vol. 19, Supplement 4, 2011; Abstract #164
U. Vitolo, A Chiappella, A. Carella, I. Baldi, B. Botto, G. Ciccone, A. Congiu, G. Gaidano, P. De Masi, M. Ladetto, A. Levis, A.M. Liberati, V. Pavone, S. Perticone, A. Tucci, M. Zanni, G. Rossi.
Lenalidomide plus Rituximab-CHOP21 is safe and effective in elderly untreated diffuse large B-CELL LYMPHOMA (DLBCL): Results of phase I part of REAL07 trial of Italian Lymphoma Foundation (FIL).
16th Annual Meeting of the European Society of Hematology (EHA) – London, UK, 9-12 June 2011
Haematologica 2011; 96 [suppl. 2] Abstract #371
A. Chiappella, P. Pregno, P. L. Zinzani, A. De Renzo, A. Evangelista, A. Fabbri, A. Ferreri, S. Franceschetti, R. Freilone, D. Gioia, A. M. Liberati, D. Novero, L. Orsucci, L. Rigacci, D. Rota-Scalabrini, C. Rusconi, E. Russo, F. Saccona, G. Specchia, V. Stefoni, A. Tucci, F. Zaja, U. Vitolo.
Weekly infusion of Rituximab and Bortezomib is effective and safe in relapsed/refractory indolent and mantle cell lymphoma: long term analysis of a phase II trial of Italian Lymphoma Foundation (FIL).
16th Annual Meeting of the European Society of Hematology (EHA) – London, UK, 9-12 June 2011
Haematologica 2011; 96 [suppl. 2] Abstract #381
U. Vitolo, A. Chiappella, A. J.M. Ferreri, M. Martelli, I. Baldi, M. Balzarotti, C. Bottelli, A. Conconi, H. Gomez, A. Lopez-Guillermo, G. Martinelli, F. Merli, D. Novero, L. Orsucci, V. Pavone, U. Ricardi, S. Storti, M. K. Gospodarowicz, F. Cavalli, A. H. Sarris and E. Zucca.
Firts-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial.
46th Annual Meeting of the American Society of Clinical Oncology (ASCO) – Chicago, IL, June 3-7, 2011
Journal of Clinical Oncology – July 10, 2011 Volume 29 no. 20 2766-2772
2010
F. Zaja, S. De Luca, U. Vitolo, L. Orsucci, A. Levis, F. Salvi, C. Rusconi, E. Ravelli, A. Tucci, C. Bottelli, M. Balzarotti, A. Santoro, E. Brusamolino, M. Bonfichi, A. Di Rocco, C. Stelitano, L. Baldini, S. A. Pileri, S. Volpetti, F. Saccona, G. Ciccone, A. Ferranti, I. Catacchio, R. Ria, A. Vacca and R. Fanin.
Salvage Treatment with Lenalidomide and Dexamethasone In Patients with Relapsed Refractory Mantle Cell Lymphoma: Clinical Results and Modifications of Angiogenic Biomarkers.
American Society of Hematology 52nd Annual Meeting and Exposion, December 4-7, 2010, Oragnge Country Convention Center, Orlando, FL
Abstract #996 appears in Blood, Volume 116, issue 21, November 19, 2010
F. Merli, S. Luminari, G. Rossi, C. Mammi, L. Marcheselli, I. Alvarez, A. Tucci, C. Stelitano, F. Ilariucci, M. Musso, L. Baldini, A. Fragasso, A. Chiappella and M. Federico.
Outcome of Elderly Frail Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Prospectively Identified by Comprehensive Geriatric Assessment (CGA). Results Froma a Study of the Intergruppo Italiano Linfomi (IIL).
American Society of Hematology 52nd Annual Meeting and Exposion, December 4-7, 2010, Oragnge Country Convention Center, Orlando, FL
Abstract #1771 appears in Blood, Volume 116, issue 21, November 19, 2010
U. Vitolo, A. Chiappella, A. M. Carella, I. Baldi, G. Ciccone, A. Congiu, G. Gaidano, P. De Masi, M. Ladetto, A. Levis, A. M. Liberati, L. Orsucci, V. Pavone, S. Perticone, A. Tucci, M. Zanni and G. Rossi.
Prospective, Multicenter Phase I-II Pilot Trial to Evaluate Efficacy and Safety of Lenalidomide Plus Rituximab-CHOP 21 (LR-CHOP21) for Elderly Patients with Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Interim Analysis of the Intergruppo Italiano Linfomi REAL07 Study.
American Society of Hematology 52nd Annual Meeting and Exposion, December 4-7, 2010, Oragnge Country Convention Center, Orlando, FL
Abstract #2871 appears in Blood, Volume 116, issue 21, November 19, 2010
L. Rigacci, P.L. Zinzani, B. Puccini, A. Broccoli, A. Gallamini, F. Merli, V. Stefoni, C. Stelitano, M. Balzarotti, P. Pregno, E. Brusamolino, F. Salvi, P. M. Stefani, R. Sancetta, R. Emili, S. Tavera, I. Capodanno, U. Vitolo, C. Pellegrini, A. M. Liberati and A. Bosi.
IHP International Criteria of Interim-PET Scan Confirms Prognostic Impact In Early Stage Hpdgkin Lymphoma Patients without Bulky Disease.
American Society of Hematology 52nd Annual Meeting and Exposion, December 4-7, 2010, Oragnge Country Convention Center, Orlando, FL
Abstract #3890 appears in Blood, Volume 116, issue 21, November 19, 2010
A. Chiappella, P. Pregno, P. L. Zinzani, A. Evangelista, A. Fabbri, F. Facchetti, A. JM. Ferreri, S. Franceschetti, R. Freilone, L. Gargantini, D. Gioia, A. M. Liberati, M. Nicolosi, L. Orsucci, L. Rigacci, E. Russo, V. Stefoni, A. Tucci and U. Vitolo.
Weekly Infusion of Bortezomib IN Combination with Rituximab In Relapsed/Refractory Indolent Non-Follicular and Mantle Cell Lymphoma Is Safe and Effective: Two-Years Analysis of Phase II Trial BRIL06 of Intergruppo Italiano Linfomi (IIL).
American Society of Hematology 52nd Annual Meeting and Exposion, December 4-7, 2010, Oragnge Country Convention Center, Orlando, FL
Abstract #3965 appears in Blood, Volume 116, issue 21, November 19, 2010
Rigacci L, Zinzani PL, Puccini B, Broccoli A, Gallamini A, Merli F, Antognoli G, Stefoni V, Stelitano C, Balzarotti M, Pregno P, Fraulini C, Salvi F, Emili R, Travera S, Capodanno I, Vitolo U, Pellegrini C, Liberati AM, Bosi A.
Early FDG-PET Scan confirms its prognostic impact also in localized stage, ABVD treated Hodgkin Lymphoma patients.
8th International Symphosium on Hodgkin Lymphoma – Cologne, Germany, October 23-26, 2010.
Haematologica 2010; Abstract book 95 (s4) s13 abs. C046
Fiore F, Viviani S, Luminari S, Levis A, Di Raimondo F, Merli F, Vitolo U, Bolis S, Federico M, Gallamini A.
Early interim FDG-PET during intesified BEACOPP therapy for advanced-stage Hodgkin disease shows a lower positive predictive value than during ABVD.
8th International Symphosium on Hodgkin Lymphoma – Cologne, Germany, October 23-26, 2010.
Haematologica 2010; Abstract book 95 (s4) s18 abs. C061
Federico M, Gobbi PG, Luminari S, Valentino F, Bassi E, Coriani C, Merli F, Bonfante V, Marchianò A, Gallamini A, Bolis S, Stelitano C, Levis A, Angrilli F, Di Giulio G, Corazza GR; Gianni AM.
Beacopp is superior to ABVD in patients with advanced Hodgkin Lymphoma and high tumor burden.
8th International Symphosium on Hodgkin Lymphoma – Cologne, Germany, October 23-26, 2010.
Haematologica 2010; Abstract book 95 (s4) s18 abs. C063
Sancetta R, Rigacci L, Puccini B, Pregno P, Vitolo U, Brusamolino E, Gotti M, Magagnoli M, Carella AM, Rossi E, Gallamini A, Chisesi T.
Is intensification of therapy in HL PET2+ patients really useful?
8th International Symphosium on Hodgkin Lymphoma – Cologne, Germany, October 23-26, 2010.
Haematologica 2010; Abstract book 95 (s4) s42 abs. P143
A. Chiappella, P. Pregno, P.L. Zinzani, A. Evangelista, A. Fabbri, F. Facchetti, A. Ferreri, S. Franceschetti, R. Freilone, L. Gargantini, D. Gioia, A.M. Liberati, L. Orsucci, L. Rigacci, E. Russo, V. Stefoni, A. Tucci, U. Vitolo.
Luminari S, Cesaretti M, Tomasello C, Guida A, Bagni B, Merli F, Postiglione R, Mangone L, Versari A, Re F, De Lisi V, Ruffini L, Ferretti s, Cuneo A, Ferico M.
The use of FDG positron emission therapy (FDG-PET) in patients with Hodgkin Lymphoma (HL) in the “real word”: a population based study from northern Italy.
8th International Symphosium on Hodgkin Lymphoma – Cologne, Germany, October 23-26, 2010.
Haematologica 2010; Abstract book 95 (s4) s42 abs. P144
Jullian A, Meignan M, Itti E, Bardet S, Edeline V, Itti E, Bardet S, Edeline V, Vanderborght T, Reman O, Ricci R, Brusamolino E, Raemaekers JMM, André M.
Comparison of visual and quantitative assesment for FDG-PET Interpretation in Hodgki Lymphoma after 2 cycles of ABVD. The EORTC-GELA-IIL H10 trial experience.
8th International Symphosium on Hodgkin Lymphoma – Cologne, Germany, October 23-26, 2010.
Haematologica 2010; Abstract book 95 (s4) s49 abs. P163
Yeddes I, Meignan M, Bardet S, Vander Borght T, Ricci R, Itti E, Lumbroso J, Edeline V, Oliver P, Borght TV, Reman O, Karcher G, Mundler O, Hutchings M, Versari A, Bellei M, Reamaekers JMM, André M.
Positive interim PET after 2 ABVD is more frequent in patients with unfavourable stage I/II Hodgkin Lymphoma and Bulky mediastinum than in non-bulky. The EORTC-GELA-IIL H10 trial experience.
8th International Symphosium on Hodgkin Lymphoma – Cologne, Germany, October 23-26, 2010.
Haematologica 2010; Abstract book 95 (s4) s49 abs. P164
A. Chiappella, P. Pregno, P.L. Zinzani, A. Evangelista, A. Fabbri, F. Facchetti, A. Ferreri, S. Franceschetti, R. Freilone, L. Gargantini, D. Gioia, A.M. Liberati, L. Orsucci, L. Rigacci, E. Russo, V. Stefoni, A. Tucci, U. Vitolo.
Efficacy and safety of bortezomib and rituximab association in relapsed/refractory indolent non follicular and mantle cell lymphoma: final results of phase II study by Intergruppo Italiano Linfomi.
15th Congress of the European Hematology Association – June 10-13 2010, Barcelona Spain
Haematologica 2010; 95 [suppl. 2]: 106 abs. 0271
M.Merli, L. Arcaini, C. Basilico, M.G. Cabras, C. Visco, A. Levis, D. Rossi, A.D’Arco, L. Rigacci, A. Ambrosetti, P. Musto, A. Tucci, A. Pulsoni, V. Ferretti, S. Rattotti, S. Rizzi, G. Gaidano, U. Vitolo, E. Morra, M. Lazzarino.
Clinical and virologic features, treatment-related toxicity and outcome of Non Hodgkin’s Lymphomas associated with Hepatitis C virus infection: a multicenter italian study on 643 patients.
15th Congress of the European Hematology Association – June 10-13 2010, Barcelona Spain
Haematologica 2010; 95 [suppl. 2]: 111 abs. 0280
F. Zaja, S. De Luca, U. Vitolo, L. Orsucci, A. Levis, F. Salvi, L. Gargantini, E. Ravelli, A. Tucci, C. Bottelli, M. Balzarotti, A. Santoro, E. Brusamolino, M. Bonfichi, A. Di Rocco, C. Stelitano, L. Baldini, S. Pileri, S. Volpetti, F. Saccona, G. Ciccone, A. Ferranti, R. Fanin, I Intergruppo Italiano Linfomi.
Salvage treatment with lenalidomide and dexamethasone in patients with relapsed refractory mantle cell Lymphoma.
15th Congress of the European Hematology Association – June 10-13 2010, Barcelona Spain
Haematologica 2010; 95 [suppl. 2]: 115 abs. 0288
A. Chiappella, M. G. Cabras, A.M. Liberati, E. Angelucci, L. Baldini, C. Bottelli, B. Botto, N. Cascavilla, G. Ciccone, S. Cortellazzo, P. De Masi, L. Falchi, G. Fioritoni, C. Frairia, R. Freilone, A. Levis, L. Orsucci, G. Parvis, E. Pogliani, D. Rota-Scalabrini, F. Salvi, G. Specchia, A. Tonso, A. Tucci, U. Vitolo.
Long-term outcome of 309 young patients with untreated diffuse large B-cell lymphoma (DLBCL) at poor prognosis: a pooled analysis from GIMURELL and Intergruppo Italiano Linfomi (IIL).
15th Congress of the European Hematology Association – June 10-13 2010, Barcelona Spain
Haematologica 2010; 95 [suppl. 2]: 279 abs. 0666
G. Benevolo, P. Pioltelli, M. Spina, C. Boccomini, A. Stacchini, A. Evangelista, L. Godio, F. Mannelli, S. Franceschetti, M. Cantonetti, A. Di Rocco, L. Depaoli, V. Pavone, N. Di Renzo, A. Ferreri, M. Arras, E. Pogliani, U. Vitolo.
Prognostic value of cerebrospinal fluid flow cytometry analysis in aggressive NHL patients at high risk for leptomeningeal disease: FCM+ may predict an high risk of CNS relapse.
15th Congress of the European Hematology Association – June 10-13 2010, Barcelona Spain
Haematologica 2010; 95 [suppl. 2]: 286 abs. 0683
L.Rigacci, P.L. Zinzani, B. Puccini, A. Broccoli, A. Gallamini, F. Merli, G. Antognoli, V. Stefanoni, C. Stelitano, M. Balzarotti, P. Pregno, C. Fraulini, F. Salvi, R. Emili, S. Tavera, I. Capodanno, U. Vitolo, C. Pellegrini, A. M. Liberati, A. Bosi.
Early FDG-PET scan confirms its prognostic impact also localized stage, ABVD treated Hodgkin Lymphoma patients.
15th Congress of the European Hematology Association – June 10-13 2010, Barcelona Spain
Haematologica 2010; 95 [suppl. 2]: 474 abs. 1149
A. Assanelli, K. Patti, S. Cortellazzo, L. Rigacci, L. Devizzi, M. Foppoli, A. Mule’, F. Ciceri, C. Tarella, A.J. Ferreri and on behalf of the Intergruppo Italiano Linfomi.
High-dose sequential chemotherapy and rituximab (R-HDS) supported by autologus stem cell transplantation (ASCT) in patients (pts) with systemic B-cell lymphoma with CNS involvement (SCNSL) at diagnosis or relapse: Interim analysis of feasibility and activity of a phase II trial.
45th Annual Meeting of the American Society of Clinical Oncology (ASCO) – Chicago, IL, June 4 – 8, 2010
Abstract 8081: Journal of Clinical Oncology – Volume 28: 2010 (May 20 Supplement)
C. Tarella, M. Ladetto, F. Benedetti, U. Vitolo, A. Pulsoni, C. Patti, V. Callea, A. Rambaldi, A. Piccin, L. Devizzi, M. Musso, E. Iannitto, P. Spedini, A.M. Liberati, F. Ciceri, A. Gallamini, F. Rodighero, G. Gini, A. De Crescenzo, F. Di Raimondo, A. Levis, T. Chisesi, T. Petrone, D.R. Scalabrini, G. Rossi, A.M. Carella, G. Parvis, I. Majolino, R. Passera, M. Ruella, A. Pileri, A.M. Gianni, P. Corradini, GITMO, IIL.
A recent update of 3 consecutive prospective trials with high-dose therapy and autograft, without or with rituximab, as primary treatment for advanced-stage follicular lymphoma shows a sizeable group of patients surviving in continuous complete remission.
36th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) – Vienna, Austria, 21-24 March 2010.
Abstract 0241: Bone Marrow Transplantation – Volume 45, Supplement S2, 2010.
2009
P. Pregno, A. Chiappella, P.L. Zinzani, L. Orsucci, V. Stenoni, E. Russo, A. Tucci, S. Franceschetti, R. Freilone, A. Fabbri, A. Ferreri, L. Gargantini, A.M. Liberati, L. Rigacci, A. Evangelista, U. Vitolo.
Activity and safety of Brotezomib and Rituximab in relapsed/refractory indolent non follicular and mantle-cell Non Hodgkin Lymphoma: a phase II multicenter study by Interguppo Italiano Linfomi.
14th Congress of the European Hematology Association – June 4-7 2009, Berlin Germany
Haematologica 2009; 94 [suppl. 2]: 167 abs. 0411
G. Benevolo, P. Pioltelli, B. Botto, A. Stracchini, A. Evangelista, M. Spina, F. Mannelli, Cantonetti, A. Di Rocco, D. Pietrasanta, V. Pavone, N. Di Renzo, A. Ferreri, M. G. Cabras, U. Vitolo, E. Pogliani.
Cerebrospinal fluid flow cytometry analisi in newly diagnosed aggressive Non Hodgkin Lymphomas at high risk for leptomeningeal: a multicentric prospective italian study.
14th Congress of the European Hematology Association – June 4-7 2009, Berlin Germany
Haematologica 2009; 94 [suppl. 2]: 167 abs. 0984
U. Vitolo, M. Ladetto, C. Boccomini, E. Gamba, I. Alvarez, L. Baldini, A. Chiappella, A. Corradini, A. De Renzo, F. Di Raimondo, A. Evangelista, A. Gallamini, A. Guarini, B. Mantoan, M. Martelli, L. Orsucci, G. Parvis, M. Petrini, A. Pinto, S. Pozzi, A. Pulsoni, L. Rigacci, E. Russo, C. Tarella, A. Tucci, F. Zaja, E. Gallo.
Brief chemoimmunoterapy Rituximab (R)-FND/-R maintenance is effective and safe in newly diagnosed follicular lymphoma elderly patients: an intergruppo italiano linfomi (IIL) randomized trial.
14th Congress of the European Hematology Association – June 4-7 2009, Berlin Germany
Haematologica 2009; 94 [suppl. 2]: 167 abs. 1041
L.Rigacci, B. Puccini, A. Gallamini, F. Merli, C. Stelitano, M. Balzarotti, P. Pregno, C. Fraulini, F. Salvi, R. Emili, S. Taverna, I. Capodanno, A. Santoro, U. Vitolo, T. Chisesi, A. Levis, A. M. Liberati, A. Bosi.
Early FDG-PET scan confirms its prognostic impact also in localized stage, ABVD treted Hodgkin Lymphoma patients.
42° Congress of the Italian Society of Hematology – 18 – 21 October 2009, Milan, Italy
Haematologica 2009; 94 [suppl. 4]: P440
M. Balzarotti, E. Brusamolino, D. Sabiu, A. Pulsoni, E. Angelucci, M. Spina, G. Rossi, U. Vitolo, A. M. Carella, E. Cavalieri, A. Levis, L. Gargantini, C. Stelitano, L. Giordano, A. Santoro.
Lack of hepatoxicity by the association of bortezomib and gemcitabine in Hodgkin’s Lymphoma (HL): Italian Lymphoma Intergroup (IIL) experience.
42° Congress of the Italian Society of Hematology – 18 – 21 October 2009, Milan, Italy
Haematologica 2009; 94 [suppl. 4]: P442
M. PE André, O. Reman, M. Federico, P. Brice, E. Brusamolino, T. Girinski, C. Ferme, E. Vander Maazen, M. Bellei, C. Sebban, F. Morschhauser, E. Lugtenburg, A. Stamatoullas, L. Baila, C. Fortpied, M. Meignan and J. M. Raemaekers
First Report ON the H10 EORTC/GELA/IIL Randomized Intergroup Trial ON Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients with Supra-Diaphragmatic Stage I/II Hodgkin’s Lymphoma, for the Groupe d’Etude Des Lymphomas De l’Adulte (GELA), European Organisation for the Research and Treatment of Cancer (EORTC) Lymphoma Group and the Intergruppo Italiano Linfomi (IIL).
Oral Session: Lymphoma: Chemotherapy, excluding Pre-Clinical Models – PET Therapeutic Strategies and Special Populations
American Society of Hematology 51st Annual Meeting and Exposion, December 5-8, 2009, New Orleans, LA
Abstract #97 appears in Blood, Volume 114, issue 22, November 20, 2009.
A. Dodero, F. Spina, F. Narni, F. Patriarca, S. Cortellazzo, F. Benedetti, F. Cicceri, D. Baronciani, R. Scime, E. Pogliani, A. Rambaldi, F. Bonifazi, A. Olivieri, B. Bruno, C. Tarella and P. Corradini.
Allogenic Stem Cell Transplantation (Allo-SCT) Following a Reduced-Intensity Conditioning (RIC) Regimen in Relapsed Peripheral T-Cell Lymphomas (PTCL): Results at 4 Year of Median Follow-up.
Oral Session: Clinical Results – Alternative Donor Trasnsplantation III
American Society of Hematology 51st Annual Meeting and Exposion, December 5-8, 2009, New Orleans, LA
Abstract #875 appears in Blood, Volume 114, issue 22, November 20, 2009.
U. Vitolo, C. Boccomini, M. Ladetto, E. Gamba, I. Alvarez, L. Baldini, A. Chiappella, A. Chiarenza, P. Corradini, A. De Renzo, A. Evangelista, A. Gallamini, A. Guarini, S. Hohaus, A. M. Liberati, B. Mantoan, L. Orsucci, G. Parvis, M. Petrini, A. Pinto, E. Pogliani, S. Pozzi, A. Pulsoni, L. Rigacci, E. Russo, C. Tarella, A. Tucci, F. Zaja and E. Gallo
Rituximab (R) Maintenance Versus Observer After Short Term Chemoimmunotherapy R-FND as First Line Tretment in Elderly Patients with Advanced Follicular Lymphoma (FL): Updates Results and Safety of the Maintenance of An Intergruppo Italiano Linfomi (IIL) Randomized Trial.
Poster Session: Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models Poster I
American Society of Hematology 51st Annual Meeting and Exposion, December 5-8, 2009, New Orleans, LA
Abstract #1706 appears in Blood, Volume 114, issue 22, November 20, 2009.
F. Zaja, S. De Luca, U. Vitolo, L. Orsucci, A. Levis, F. Salvi, L. Gargantini, E. Ravelli, A. Tucci, C. Bottelli, M. Balzarotti, A. Santoro, E. Brusamolino, M. Bonfichi, A. Di Rocco, C. Stelitano, L. Baldini, S. A. Pileri, S. Volpetti, G. Ciccone, A. Ferranti and R. Fanin.
Salvage Tretment with Lenalidomide and Dexamethasone in Patients with Relapsed Refractori Mantle Cell Lymphoma.
Poster Session: Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models Poster I
American Society of Hematology 51st Annual Meeting and Exposion, December 5-8, 2009, New Orleans, LA
Abstract #1713 appears in Blood, Volume 114, issue 22, November 20, 2009.
A. Chiappella, M. G. Cabras, A. M. Liberati, C. Bottelli, G. Ciccone, E. Angelucci, L. Baldini, B. Botto, N. Cascavilla, S. Cortellazzo, P. De Masi, L. Falchi, G. Fioritoni, C. Frairia, R. Freilone, A. Levis, L. Orsucci, G. Parvis, E. M. Pogliani, D. R. Scalabrini, F. Salvi, G. Specchia, A. Tonso, A. Ticci and U. Vitolo.
Long-Term Outcome of 309 Young Patients Affected by Diffuse Large B-Cell Lymphoma (DLBCL) with a Poor-Prognosis at Diagnosis: a Pooled Analysis From Four Consecutive Trials of GIMURELL and Italian Lymphoma Intergroup.
Poster Session: Clinical Results – Autologus Transplantation Poster II
American Society of Hematology 51st Annual Meeting and Exposion, December 5-8, 2009, New Orleans, LA
Abstract #2316 appears in Blood, Volume 114, issue 22, November 20, 2009.
L. Baldini, A. Pulsoni, G. Rossi, U. Vitolo, E. Morra, B. Oliviero, E. Cavalieri, F. Merli, L. Rigacci, F. Nobile, A. Ferrario, L. Orsucci, M. Brugiatelli, P. Musto, G. L. Deliliers and E. Gamba.
Front-Line Chemo-Immunotherapy Rituximab-FC + Rituximab Maintenance in Patients with Untreated Advance Stage Non Follicular Lymphoma (INFL): Update of a Prospective Study of the Intergruppo Italiano Linfomi and Roche (ML18324).
Poster Session: Lymphoma: Chemotherapy, excluding Pre-Clincal Models Poster II
American Society of Hematology 51st Annual Meeting and Exposion, December 5-8, 2009, New Orleans, LA
Abstract #2686 appears in Blood, Volume 114, issue 22, November 20, 2009.
A. JM Ferreri, C. Verona, L. S. Politi, L. Perna, A. Chiara, M. Foppoli, G. Licata, S. Mappa, F. Ciceri, P. Picozzi, A. Franzin, S. Govi, M. Ponzoni, M. R. Terreni, E. Villa and M. Reni.
Post-Chemotherapy Brain Irradiation in Primary CNS Lymphomas: Impact on Survival of DIfferent Fields and Doses.
Poster Session: Lymphoma: Chemotherapy, excluding Pre-Clincal Models Poster II
American Society of Hematology 51st Annual Meeting and Exposion, December 5-8, 2009, New Orleans, LA
Abstract #2696 appears in Blood, Volume 114, issue 22, November 20, 2009.
J. M. Vose, T. Hebermann, M. S. Czuczman, P. L. Zinzani, C. B. Reeder, J. Tuscano, I. S. Lossos, D. Pietronigro, A. E. Haynes and T. Witzig.
Single-Agent Lenalidomide for Patients with Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma Who Had Received Prior Stem Cell Transplant.
Poster Session: Lymphoma: Chemotherapy, excluding Pre-Clincal Models Poster II
American Society of Hematology 51st Annual Meeting and Exposion, December 5-8, 2009, New Orleans, LA
Abstract #2699 appears in Blood, Volume 114, issue 22, November 20, 2009.
P. L. Zinzani, M. Fina, M. Tani, V. Stefoni, L. Gandolfi, A. Boccoli, C. Pellegrini, E. Derenzini, G. Rossi, E. Angelucci, G. Gaidano, M. C. Petti, M. Martelli, U. Vitolo, S. Fanti and M. Baccarani.
A Phase II Trial of Rituximab-CHOP Chemotherapy Followed by Yttrium 90 (90Y) Ibritumomab Tiuxetan (90Y-IT) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.
Poster Session: Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models Poster II
American Society of Hematology 51st Annual Meeting and Exposion, December 5-8, 2009, New Orleans, LA
Abstract #2720 appears in Blood, Volume 114, issue 22, November 20, 2009.
A. Chiappella, P. Pregno, P. L. Zinzani, F. Facchetti, A. Evangelista, A. Fabbri, A. JM Ferreri, S. Franceschetti, R. Freilone, L. Gargantini, D. Gioia, A. M. Liberati, L. Orsucci, L. Rigacci, E. Russo, V. Stefoni, A. Tucci and U. Vitolo.
The Combination of Brotezomib and Rituximab Is Effective and Safe in Relapsed/Refractory Indolent Non Follicular and Mantle-Cell Non Hodgkin Lymphoma: a Phase II Multicenter Study by Intergruppo Italiano Linfomi.
Poster Session: Lymphoma: Therapy with Biologic Agents, excluding Pre-Clinical Models Poster III
American Society of Hematology 51st Annual Meeting and Exposion, December 5-8, 2009, New Orleans, LA
Abstract #3758 appears in Blood, Volume 114, issue 22, November 20, 2009.
M. Scandurra, M. Mian, C. P. De Campos, P. M. V. Ranconicta, T. C. Greiner, W. C. Chan, J. M. VOse, G. Inghirami, A. Chiappella, L. Baldini, M. Ponzoni, A. JM Ferreri, S. M. Moreno, M. A. Piris, S. Franceschetti, G. Gaidano, F. Facchetti, A. Tucci, T. Lazura, O. Lambotte, S. Uccella, M. G. Tibiletti, G. Pinotti, G. Pruneri, G. Martinelli, J. F. Nomdedeu, E. Chigrinova, A. Rinaldi, E. Zucca, I. Kwee and F. Bertoni.
Subgroups of Diffuse Large B-Cell Lymphoma (DLBCL) with Different Genomic Lesions and Clinical Course Treatment with R-CHOP.
Poster Session: Non-Hodgkin’s Lymphoma – Gyology, excluding Therapy Poster III
American Society of Hematology 51st Annual Meeting and Exposion, December 5-8, 2009, New Orleans, LA
Abstract #3957 appears in Blood, Volume 114, issue 22, November 20, 2009.
2008
A. M. Gianni, A. Rambaldi, P. Zinzani, A. Levis, E. Brusamolino, A. Pulsoni, M. Liberati, E. Pogliani, S. Cortellazzo, P. Valagussa.
Comparable 3-year outcome following ABVD or BEACOPP first-line chemotherapy, plus pre-planned high-dose salvage, in advanced Hodgkin lymphoma (HL): A randomized trial of the Michelangelo, GITIL and IIL cooperative groups.
44th Annual Meeting of the American Society of Clinical Oncology (ASCO) – Chicago, IL, May 30 – June 3, 2008
Abstract 8506: Journal of Clinical Oncology – Volume 26: 2008 (May 20 suppl)
M. Martelli.
Rituximab does not improve survival of patients treated with M/VACOP-B plus radiotherapy in primary mediastinal large B-cell Lymphoma (PMLBCL): an italian phase II study of Intergruppo Italiano Linfomi (IIL).
10th International Conference on Malignant Lymphoma. 4-7 June, 2008: Lugano, Switzerland
Abstract 044: Annals of Oncology – Volume 19, 2008 Supplement 4
U. Vitolo, E. Zucca, A. Chiappella, M. Balzarotti, C. Bottelli, A. Conconi, P. De Masi, H. Gomez, A. Lopez-Guillermo, M. Martelli, G. Martinelli, F. Merli, V. Naso, L. Orsucci, V. Pavone, V. Seconso, S. Storti, M. Gospodarowicz, A. Sarris, F. Cavalli.
Rituximab ® CHOP with CNS and contralateral testis prophylaxis improves the outcome of primary testicular lymphoma (PTL): final results of IELSG10 study.
10th International Conference on Malignant Lymphoma. 4-7 June, 2008: Lugano, Switzerland
Abstract 063: Annals of Oncology – Volume 19, 2008 Supplement 4
A. Gallamini, C. Agostinelli, L. Rigacci, F. D’Amore, F. Merli, P. Zinzani, U. Vitolo, C. Patti, C. Stelitano, F. Di Raimondo, A. Levis, L. Trentin, T. Chisesi, P. Lamper, S. Pileri.
The prognostic value of the tumor/microenvironment signature compared to early PET scan in advanced-stage, ABVD-treated Hodgkin Lymphoma patients.
10th International Conference on Malignant Lymphoma. 4-7 June, 2008: Lugano, Switzerland
Abstract 129: Annals of Oncology – Volume 19, 2008 Supplement 4
F. Merli, S. Luminari, A. Tucci, P. Pregno, M. Musso, M. Martelli, C. Stelitano, L. Baldini, P. Mazza, D. Vallisa, F. Salvi, E. Barbolini, A. M. Liberati, C. Bottelli, F. Ilariucci, M. Federico.
Phase III randomized trial comparing R-CHOP vs R-miniCEOP in elderly patients with diffuse large B-cell Lymphoma (B-DLCL) prospectively selected by a multidimensional evaluation scale.
10th International Conference on Malignant Lymphoma. 4-7 June, 2008: Lugano, Switzerland
Abstract 213: Annals of Oncology – Volume 19, 2008 Supplement 4
U. Vitolo, M. Ladetto, C. Boccomini, E. Gamba, L. Baldini, M. Ceccarelli, A. Chiappella, A. De Renzo, F. Di Raimondo, A. Gallamini, B. Mantoan, M. Martelli, I. Alvarez, G. Parvis, M. Petrini, A. Pinto, S. Pozzi, A. Pulsoni, L. Rigacci, A. Tucci, F. Zaja, E. Gallo.
Elderly patients with untreated advanced stage follicular lymphoma (FL) treated with brief chemoimmunotherapy rituximab ® FND +/- rituximab maintenance: preliminary analysis of a prospective randomized study.
10th International Conference on Malignant Lymphoma. 4-7 June, 2008: Lugano, Switzerland
Abstract 333: Annals of Oncology – Volume 19, 2008 Supplement 4
S. Cortellazzo, M. Mian, R. Tsang, A. Rossi, M.E. Cabrera, M. Federico, E. Zucca, M. Busetto, A. Rambaldi and F. Cavalli, on behalf of IELSG and IIL.
Primary extranodal follicular lymphoma of head and neck (PEFLHN): a rare disease with a poor clinical outcome (IELSG23).
13th Congress of the European Hematology Association – Copenaghen, Denmark, June 12 – 15, 2008
Abstract 0266: Haematologica vol 93 – suppl. 1: June 2008
U. Vitolo, E. Zucca, M. Martelli, A. Chiappella, M. Balzarotti, G. Benevolo, P. De Masi, A. Filippi, M.K. Gospodarowicz, A. Lopez-Guillermo, G. Martinelli, F. Merli, T. Perrone, P. Pregno, A.H. Sarris, S. Storti and F. Cavalli on the behalf of IELSG and IIL.
Primary diffuse large B-cell lymphoma of the testis: improved outcome with rituximab-CHOP CNS and contralateral testis prophilaxis. Final results of IELSG 10 study.
13th Congress of the European Hematology Association – Copenaghen, Denmark, June 12 – 15, 2008
Abstract 0401: Haematologica vol 93 – suppl. 1: June 2008
U. Vitolo, M. Ladetto, C. Boccomini, E. Gamba, I. Alvarez, L. Baldini, M. Ceccarelli, A. Chiappella, P. Corradini, A. De Renzo, F. Di Raimondo, A. Gallamini, A. Guarini, B. Manotan, M. Martelli, V. Naso, G. Pavaris, M. Petrini, P.Pinto, S. Pozzi, A. Pulsoni, L. Rigacci, C. Tarella, A. Tucci, F. Zaja, E. Gallo.
Brief chemoimmunotherapy with rituximab (R)-FND + R maintenance as first line treatment in advanced follicular lymphoma (FL) in elderly : preliminary analysis of a retrospective randomized trial.
13th Congress of the European Hematology Association – Copenaghen, Denmark, June 12 – 15, 2008
Abstract 0434: Haematologica vol 93 – suppl. 1: June 2008
A. Gallamini, M. Hutchings, L. Rigacci, L. Specht, F. Merli, M. Hansen, C. Patti, A. Loft, F.Di Raimondo, F. D’Amore, A. Biggi, P. Pregno, C. Stelitano, R. Sancetta, L. Trentin, S. Luminari, E. Iannitto, S. Viviani, I. Pierri, P. Torchio, A. Levis.
Early interim FDG-PET in advanced-stage Hodgkin Lymphoma (HL). Long-term results of the Italian-Danish cooperative study.
13th Congress of the European Hematology Association – Copenaghen, Denmark, June 12 – 15, 2008
Abstract 0469: Haematologica vol 93 – suppl. 1: June 2008
R. Sancetta, C. Fraulini, L. Rigacci, B. Puccini, P. Pregno, U. Vitolo, E. Brusamolino, M. Gotti, M. Magagnoli, M. Balzarotti, A. M. Carella, E. Rossi, A. Gallamini, T. Chisesi.
Is early intensification useful for PET2+ HL patients?
13th Congress of the European Hematology Association – Copenaghen, Denmark, June 12 – 15, 2008
Abstract 0616: Haematologica vol 93 – suppl. 1: June 2008
M. Martelli, V. Stefoni, E. Russo, G. Cabras, A. Rossi, E. Brusamolino, A. Levis, B. Botto, V. Naso, E. Finolezzi, A. Di Rocco, R. Foà, P.L. Zinzani.
Rituximab does not improve survival of patients treated with M/VACOP-B plus radiotherapy in primary mediastinal large B-cell Lymphoma (PMLBCL): an italian phase II study of Intergruppo Italiano Linfomi (IIL).
13th Congress of the European Hematology Association – Copenaghen, Denmark, June 12 – 15, 2008
Abstract 0771: Haematologica vol 93 – suppl. 1: June 2008
A. JM Ferreri, M. Reni, M. Foppoli, M. Martelli, M. Siakantaris, M. Frezzato, M. G. Cabras, A. Fabbri, G. Corazzelli, F. Ilariucci, G. Rossi, R. Soffietti, C. Stelitano, D. Vallisa, F. Zaja, M. Gelemur, G. M. Aondio, G. Avvisati, M. Balzarotti, A. Brandes, M. Joao Costa, H. Gomez, A. Guarini, G. Pinotti, L. Rigacci, C. Uhlmann, M. Angelopoulou, M. Tirindelli, V. Naso, A. Franzin, N. Anzalone, M. Ponzoni, E. Zucca, F. Caligaris-Cappio and F. Cavalli.
Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-Dose Cytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Events-Free Survival Analysis.
Oral Session
American Society of Hematology 50th Annual Meeting and Exposion, December 6-9, 2008, San Francisco, CA
Abstract #580 appears in Blood, Volume 112, issue 11, November 16, 2008
U. Vitolo, M. Ladetto, C. Boccomini, E. Gamba, I. Alvarez, L. Baldini, A. Chiappella, P. Corradini, A. De Renzo, F. Di Raimondo, A. Evangelista, A. Gallamini, A. Guarini, G. Leone, A. M. Liberati, B. Mantoan, M. Martelli, L. Orsucci, G. Parvis, M. Petrini, A. Pinto, E. Pogliani, S. Pozzi, A. Pulsoni, L. Rigacci, C. Tarella, A. Tucci, F. Zaja and E. Gallo.
Brief Chemoimmunotherapy Rituximab (R)-FND + Maintenance as First Line Treatment in Elderly Patients with Advanced Follicular Lymphopma (FL): Preliminary Analysis of a Prospective Randomized IIL Trial.
Oral Session
American Society of Hematology 50th Annual Meeting and Exposion, December 6-9, 2008, San Francisco, CA
Abstract #834 appears in Blood, Volume 112, issue 11, November 16, 2008
L. Rigacci, B. Puccini, F. Merli, C. Stelitano, P. Pregno, C. Fraulini, F. Salvi, R. Emili, I. Capodanno, U. Vitolo, T. Chisesi, A. Levis, A. M. Liberati and A. Bosi.
Early FDG-PET Scan Confirms Its Prognostic Impact Also in Localized Stage, ABVD Treated Hodgkin Lymphoma Patients.
Poster Session
American Society of Hematology 50th Annual Meeting and Exposion, December 6-9, 2008, San Francisco, CA
Abstract #1450 appears in Blood, Volume 112, issue 11, November 16, 2008
L. Baldini, A. Pulsoni, G. Rossi, U. Vitolo, E. Morra, B. Olivero, E. Cavalieri, F. Merli, L. Rigacci, F. Nobile, L. Orsucci, M. Brugiatelli, P. Musto, G. Lambertenghi Deliliers, and E. Gamba.
Front-Line Chemo-Immunotherapy Rituximab-FC + Rituximab Maintenance in Patients with Untreated Advanced Stage Non Follicular Lymphoma (INFL): Preliminary Results of a Prospective Study of the Intergruppo Italiano Linfomi and Roche (ML18324).
Poster Session
American Society of Hematology 50th Annual Meeting and Exposion, December 6-9, 2008, San Francisco, CA
Abstract #2009 appears in Blood, Volume 112, issue 11, November 16, 2008
T. Chisesi, M. Bellei, S. Luminari, L. Marcheselli, A. Levis, U. Vitolo, C. Stelitano, V. Pavone, F. Merli, M. Liberati, L. Baldini, R. Bordonaro, E. Pesce, P. Gobbi and M. Federico.
Long Term Follow-up Analysis of HD9601 Trial Comparing ABVD Vs Stanford V vs MOPPABVCAD in Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma. A Study from the Intergruppo Italiano Linfomi (IIL).
Poster Session
American Society of Hematology 50th Annual Meeting and Exposion, December 6-9, 2008, San Francisco, CA
Abstract #2602 appears in Blood, Volume 112
2007
M. Ladetto, F. De Marco, F. Benedetti, U. Vitolo, C. Patti, A. Rambaldi, A.M. Liberati, M. Musso, A. Pulsoni, A. Olivieri, E. Pavone, E. Pogliani, D. Rota Scalabrini, A. Gallamini, V. Callea, I. Ricca, M. Boccadoro, I. Majolino, P. Corradini, A.M. Gianni, C. Tarella on behalf of GITMO/IIL.
Multicentre randomized GITMO-IIL trial in high-risk follicular lymphoma at diagnosis: rituximab supplemented high-dose sequential chemotherapy is superior to CHOP-R in molecular remission rate, EFS and PFS.
33rd Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) – Lyon, France, 25-28 March 2007
Abstract P654: Bone Marrow Transplantation – Volume 39, Supplement S1, 2007
M. Ladetto, F. De Marco, F. Benedetti, U. Vitolo, C. Patti, R. Passera, A. Rambaldi, A.M. Gianni, P. Corradini, C. Tarella, On behalf of GITMO/IIL.
Prospective, multicenter, randomized GITMO-IIL trial comparing intensive (R-HDS) to conventional chemoimmunotherapy (CHOP-R) in high-risk follicular lymphoma (FL) at diagnosis.
43nd Annual Meeting of the American Society of Clinical Oncology (ASCO) – Chicago, IL, 1-5 June 2007
Abstract 8006: Journal of Clinical Oncology – Volume 25, N. 18S (June 20 Supplement), 2007
M. Ladetto, F. De Marco, F. Benedetti, U. Vitolo, C. Patti, A. Rambaldi, A. Pulsoni, M. Musso, A. M. Liberati, A. Olivieri, A. Gallamini, E. Pogliani, D. Rota Scalabrini, V. Callea, F. Di Raimondo, V. Pavone, A. Tucci, S. Cortellazzo, A. Levis, M. Boccadoro, I. Majolino, A. Pileri, A. M. Gianni, R. Passera, P. Corradini, C. Tarella.
Prospective, Multicenter Randomized GITMO/IIL Trial Comparing Intensive (R-HDS) Versus Conventional Chemoimmunotherapy (CHOP-R) in High-Risk Follicular Lymphoma at Diagnosis: The Superior Molecular Remission (MR) Rate of R-HDS explains its Better Clinical Performance.
12th Congress of the European Hematology Association – Vienna, Austria, June 7-10, 2007
Abstract 0406: Haematologica vol 92 – suppl. 1: June 2007
U. Vitolo, M. G. Cabras, G. Rossi, A. M. Liberati, A. Chiappella, A. Levis, E. Angelucci, V. Pavone, B. Botto, G. Ciccone, R. Freilone, G. Gaidano, D. Novero, L. Orsucci, I. Palumbo, E. M. Pogliani, D. Rota Scalabrini, F. Salvi, A. Tonso, A. Tucci, E. Gallo.
Addition of Rituximab to Dose-Dense and High Dose Chemotherapy (HDC) with Autologus Transplantation (ASCT) in Untreated Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Results of Phase II Trial.
12th Congress of the European Hematology Association – Vienna, Austria, June 7-10, 2007
Abstract 0408: Haematologica vol 92 – suppl. 1: June 2007
M. Martelli, V. Stefoni, P. Cabras, A. Rossi, E. Brusamolino, A. Levis, B. Botto, E. Calabrese, E. Russo, E. Finolezzi, A. Di Rocco, R. Foà, P.L. Zinzani on behalf of Intergruppo Italiano Linfomi (IIL).
Rituximab combined with M/VACOP-B and raditotherapy in primary mediastinal large B-cell lymphoma (PMLBCL): a prospective italian phase II study of Intergruppo Italiano Lifnomi (IIL).
41th Congress of the Italian Society for Hematology – Bologna, Italy, October 14-17, 2007
Abstract CO-004: Haematologica vol 92 – suppl. 3: October 2007
U. Vitolo, M. Martelli, G. Martinelli, I. Baldi, M. Balzarotti, A. Chiappella, A. Conconi, P. De Masi, F. Merli, L. Orsucci, V. Pavone, U. Ricardi, V. Secondo, S. Storti, A. Tucci, E. Zucca, E. Gallo.
Prospective IELSG/IIL study in primary diffuse large B-cell lymphoma of the testis (PTL): improved outcome with rituximab (R)-CHOP with CNS and contralateral testis prophylaxis.
41th Congress of the Italian Society for Hematology – Bologna, Italy, October 14-17, 2007
Abstract CO-005: Haematologica vol 92 – suppl. 3: October 2007
S. Cortellazzo, M. Mian, A. Rossi, E. Oldani, M. E. Cabrera, M. Federico, M. Bellei, S. Magrini, M. Buglione, M. Martelli, H. Gomez, A. L. Guillermo, E. Pogliani, F. Rossini, G. Gaidano, A. Conconi, M. Busetto, A. M. Scattolin, C. Visco, R. Tsang, E. Zucca, A. Rambaldi and F. Cavalli on behalf of IELSG and IIL.
Primary extranodal diffuse large B-cell lymphomas (DLBCL) arising in distinct sites of head and neck have different clinical characteristics and outcome.
12th Congress of the European Hematology Association – Vienna, Austria, June 7-10, 2007
Abstract 0863: Haematologica vol 92 – suppl. 1: June 2007
M. Ladetto, F. De Marco, F. Benedetti, U. Vitolo, C. Patti, A. Rambaldi, A. Pulsoni, M. Musso, A.M. Liberati, A. Olivieri, A. Gallamini, E. Pogliano, D. Rota Scalabrini, V. Callea, F. Di Raimondo, V. Pavone, A. Tucci, S. Cortellazzo, A. Levis, M. Boccadoro, I. Majolino, A. Pileri, A. M. Gianni, R. Passera, P. Corradini and C. Tarella.
Long-Term Follow-Up of the Randomized GITMO/IIL Trial Comparing CHOP-Rituximab vs. High-Dose Therapy with Rituximab (R-HDS) in High Risk Follicular Lymphoma (FI): Updated Results Suggest the Use of R-HDS as Salvage Treatment.
Oral Session
American Society of Hematology 49th Annual Meeting and Exposion, December 8-11, 2007, Georgia World Congress Center, Atlanta GA
Abstract #20 appears in Blood, Volume 110, issue 11, November 16, 2007
U. Vitolo, M. Ladetto, E. Gamba, L. Baldini, M. Ceccarelli, A, Cjiappella, A. De Renzo, F. Di Raimondo, A. Gallamini, A. Guarini, B. Mantoan, M. Martelli, I. Alvarez, L. Orsucci, G. Paravis, M. Petrini, A. Pinto, E. M. Pogliani, S. Pozzi, A. Pulsoni, L. Rigacci, A. Tucci, F. Zaja and E. Gallo.
Front-Line Brief Chemo-Immunotherapy Rituximab (R)-FND + Rituximab Consolidation + Rituximab Maintenance in Elderly Patients with Untreated Advanced Stage Follicular Lymphoma (FL): First Interim Analysis of a Prospective Randomized Study (ML17638).
Poster Session
American Society of Hematology 49th Annual Meeting and Exposion, December 8-11, 2007, Georgia World Congress Center, Atlanta GA
Abstract #1278 appears in Blood, Volume 110, issue 11, November 16, 2007
A. Levis, F. Merli, S. Tamiazzo, A. Arcari, M. Bellei, M. Brugiatelli, M. Federico, M. Liberati, G. Partesotti, P. Pregno, D. Rota Scalabrini, D. Sabiu, F. Salvi and C. Stelitano.
ABVD Versus VEPEMB in Elderly Hodgkin’s Lymphoma Patients.
Poster Session
American Society of Hematology 49th Annual Meeting and Exposion, December 8-11, 2007, Georgia World Congress Center, Atlanta GA
Abstract #2322 appears in Blood, Volume 110, issue 11, November 16, 2007
F. Merli, S. Luminari, A. Tucci, P. Pregno, M. Musso, M. Martelli, C. Stelitano, L. Baldini, P. Mazza, D. Vallisa, F. Salvi, E. Barbolini, R. Scalone, A. Di Rocco, A. Fragrasso, A. M. Liberati, C. Bottelli, L. Orsucci, F. Ilariucci, L. Marcheselli and M. Federico.
R-CHOP vs R-MiniCEOP in Elderly Patients with Diffuse Large B-Cell Lymphoma (B-DLCL) Prospectively Selected by a Multidimensional Evalutation Scale: Preliminary Results of a Randomized Study Performed by Intergruppo Italiano Linfomi (IIL).
Poster Session
American Society of Hematology 49th Annual Meeting and Exposion, December 8-11, 2007, Georgia World Congress Center, Atlanta GA
Abstract #3429 appears in Blood, Volume 110, issue 11, November 16, 2007
S. Cortellazzo, G. Gaidano, M. Mian, A. Conconi, A. Rossi, M. E. Cabrera, M. Federico, M. Bellei, S. Magrini, M. Martelli, H. Gomez, A. Lopez-Gullermo, E. M. Pogliani, F. Rossini, M. Busetto, C. Visco, R. Tsang, E. Zucca, A. Rambaldi and Franco Cavalli.
Primary Thyroid Lymphoma: A Retrospective IELSG and IIL Analysis of Clinical Characteristics, Prognostic Factors, Treatment Outcome and Somatic Hypermutation for Localized Diffuse Large B-Cell Lymphoma (DLBCL).
Poster Session
American Society of Hematology 49th Annual Meeting and Exposion, December 8-11, 2007, Georgia World Congress Center, Atlanta GA
Abstract #3432 appears in Blood, Volume 110, issue 11, November 16, 2007
2006
M. Ladetto, F. Benedetti, U. Vitolo , C. Patti, A. Rambaldi, A. Liberati, M. Musso, A. Pulsoni, A. M. Gianni, C. Tarelle on behalf of GITMO/IIL. Rituximab-supplemented high-dose sequential chemotherapy (R-HDS) has better EFD and PFS than R-CHOP in poor risk follicular lymphoma (FL) at diagnosis: a multicenter randomized GITMO/IIL Trial.
42nd Annual Meeting of the American Society of Clinical Oncology (ASCO) – Atlanta, GA, 2-6 June 2006
Abstract 7525: Journal of Clinical Oncology – Volume 24, Supplement 18s, 2006
M. Martelli, V. Stefoni, P. Cabras, S. Cortellazzo, E. Brusamolino, A. Levis, E. Gallo, A. De Vivo, F. Natalino, E. Finolezzi, A. Di Rocco, R. Foà, P. L. Zinzani.
Rituximab-M/VACOP-B combined with radiotherapy in primary mediastin large B cell lymphoma: a prospective Italian Intergoup Phase II study.
11th congress of the European Hematology Association – Amsterdam, the Netherlands, June 15-18, 2006
Abstract 0184: Haematologica vol 91 – s1, suppl. n. 1: June 2006
L. Rigacci, F. Merla, A. Castagnoli, A. Versari, L. Nassi, T. Chisesi, A. Gallamini, A. Biggi, U. Vitolo, R. Sancetta, P. Pregno, F. Salvi, A. M. Scattolin, A. Levis ed A. Bosi.
Comparison between 2-deoxy-2-[18F] fluoro-D-Glucose positron emission (FDG-PET) and computer thomography (CT) for staging of patients with Hodgkin’s Lymphoma (HL).
11th congress of the European Hematology Association – Amsterdam, the Netherlands, June 15-18, 2006
Abstract 0206: Haematologica vol 91 – s1, [suppl. n. 1]: June 2006
R. Sancetta, M. Gregianin, F. Dei Rossi, E. Cracco, P. Pregno, U. Vitolo, L. Rigacci, F. Merli, T. Chisesi.
What’s the significate of FDG-PET/CT Scan at Diagnosis of non Hodgkin’s Lymphomas?
11th congress of the European Hematology Association – Amsterdam, the Netherlands, June 15-18, 2006
Abstract 0708: Haematologica vol 91 – s1, [suppl. n. 1]: June 2006
A. Gallamini.
Predictive value on treatment outcome of early [18F] – FDG PET Scan in advanced stage Hodgkin’s disease treated by conventional chemotherapy is superior to IPS score.
11th congress of the European Hematology Association – Amsterdam, the Netherlands, June 15-18, 2006
Abstract 0987: Haematologica vol 91 – s1, [suppl. n. 1]: June 2006
U. Vitolo, E. Zucca, M. Martelli, A. Chiappella, I. Baldi, M. Balzarotti, A. Conconi, H. Gomez, A. Lopez-Guillermo, G. Martinelli, L. Orsucci, V. Pavone, G. Rossi, S. Storti, M. K. Gospodarowicz, F. Cavalli, A. H. Sarris.
Primary diffuse large B-cell lymphoma of the testis (PTL): a prospective study of Rituximab (R)-CHOP with CNS and contralateral testis prophylaxis. Results of the IELSG10 Study.
Session type: oral session.
American Society of Hematology 48th Annual Meeting and Exposion, December 9-12, 2006, Orange Country Convention Center.
Abstract #208 appears in Blood, Volume 108, issue 11, November 16, 2006
M. Ladetto, F. De Marco, F. Benedetti, U. Vitolo, C. Patti, A. Rambaldi, A. M. Liberati, M. Musso, A. Pulsoni, A. Olivieri, E. Pavone, E. Pogliani, D. R. Scalabrini, A. Gallamini, V. Callea, I. Ricca, M. Boccadoro, I. Majolino, P. Corradini, A. M. Gianni, C. Tarella on behalf of GITMO (Gruppo Italiano Trapianto di Midollo Osseo), Italy.
Clinical and molecular results of the multicenter randomized GITMO-IIL trial in poor risk follicular lymphoma (FL) at diagnosis: Rituximab-supplemented high-dose sequential chemotherapy (R-HDS) is superior to CHOP-R in molecular remissions rate, EFS and PFS.
Session type: oral session.
American Society of Hematology 48th Annual Meeting and Exposion, December 9-12, 2006, Orange Country Convention Center.
Abstract #325 appears in Blood, Volume 108, issue 11, November 16, 2006
L. Arcaini, M. Paulli, S. Burcheri, E. Boveri, A. Rossi, M. Spina, F. Passamonti, M. Montanari, A. Gallamini, L. Uziel, M. Crugnola, F. Montanari, C. Pascutto, E. Morra, M. Lazzarino I.I.L., Intergruppo Italiano Linfomi.
Clinical features and prognostic assessment of nodal marginal zone B-cell lymphoma, a rare disease with follicular-like behaviour.
Session type: Poster Session, Board #605-II.
American Society of Hematology 48th Annual Meeting and Exposion, December 9-12, 2006, Orange Country Convention Center.
Abstract #2427 appears in Blood, Volume 108, issue 11, November 16, 2006
A. Gallamini, M. Hutchings, L. Rigacci, L. Specht, F. Merli, F. D’Amore, L. Nassi, M. Hansen, U. Vitolo, P. Kamper, L. Trentin, C. Stelitano, F. Di Raimondo, R. Sancetta, S. Luminari, S. Viviani, E. Iannitto, A. Levis.
Advenced stage Hodgkin Lymphoma: the predictive value on treatment outcome of early FDG-PET scan is indipendent of and superior to IPS score.
Session type: pubblication only.
American Society of Hematology 48th Annual Meeting and Exposion, December 9-12, 2006, Orange Country Convention Center.
Abstract #4592 appears in Blood, Volume 108, issue 11, November 16, 2006
M. Martelli, V. Stefopni, G. Cabras, S. Cortellazzo, E. Brusamolino, A. Levis, B. Botto, A. DeVivo, F. Natalino, F. Erica, R. Foa, P.L. Zinzani.
Rituximab combined with M/VACOP-B and radiotherapy in primary mediastinal large B-cell lymphoma (PMLBCL): a prospective italian phase II IIL Study.
Session type: pubblication only.
American Society of Hematology 48th Annual Meeting and Exposion, December 9-12, 2006, Orange Country Convention Center.
Abstract #4697 appears in Blood, Volume 108, issue 11, November 16, 2006
Anni precedenti: dal 2005 al 2000
G. F. Ryan, G. Martinelli, K. Yuen, J. Seymour.
Primary non-Hodgkin’s Lymphoma of the breast: first report of the multicentre retrospective study of the International Extranodal Lymphoma Study Group (IELSG-15).
41st Annual Meeting of the American Society of Clinical Oncology (ASCO) Orlando, FL, 13-15 May 2005.
Abstract 6575: Journal of Clinical Oncology – Volume 23 N. 16S, Part I of II (June 1 Supplement), 2005
A. Liberati, P. Cerroni, R. Zanotti, M. Spina, S. Viviani, G. Cervetti, C. Stelitano, P. Ferrara, M. Merluzzi, U. Vitolo, Intergruppo Italiano Linfomi.
Features of relapsed disease in lymphocite predominant Hodgkin’s disease patients.
41st Annual Meeting of the American Society of Clinical Oncology (ASCO) Orlando, FL, 13-15 May 2005.
Abstract 6688: Journal of Clinical Oncology – Volume 23 N. 16S, Part I of II (June 1 Supplement), 2005
A. Gallamini, C. Agostinelli, P. Went, G. Todeschini, P. L. Zinzani, M. Liberati, G. Leonardi, M. Bellei, M. Federico, S. Taverna, S. Pileri.
Validation of PIT prognostic model on a new cohort of a patients with a centrally reviewed diagnosis of pheripheral T-cell Lymphoma, unspecified (PTCL-U).
10th Congress of the European Hematology Association – Stockholm, Sweden, June 2-5, 2005.
Abstract 0262: Haematologica vol 90 – s2, [suppl. n. 2]: June 2005
S. Cortellazzo, A. Rossi, M. Federico, A. Peveri, M. Martelli, A. Lopez Guillermo, E. Oldani, F. Rossini, E. Zucca, A. R. Conconi, M. Busetto, G. Gaidano, T. Barbui and F. Cavalli, on behalf of IELSG and IIL.
Therapeutic management, prognostic factors and clinical outcome of 416 patients with primary extranodal head and neck non-Hodgkin’s lymphoma (IELSG23).
10th Congress of the European Hematology Association – Stockholm, Sweden, June 2-5, 2005.
Abstract 0785: Haematologica vol 90 – s2, [suppl. n. 2]: June 2005
S. Cortellazzo, S. Luminari, M. Bellei, M. Martelli, U. Vitolo, L. Rigacci, A. Ambrosetti, E. Pogliani, T. Chisesi, G. Rossi, A. Rossi, T. Barbui, M. Brugiatelli, M. Federico.
A predictive model for limited stage diffuse large B-cell Lymphoma (DLBCL): a retrospective analysis of 1,252 cases performed by the Intergruppo Italiano Linfomi (IIL).
9th International Conference on Malignant Lymphoma – Lugano, Switzerland 8-11 June 2005.
Abstract 202: Annals of Oncology Volume 16, 2005 Supplement 5
S. Cortellazzo, A, Rossi, M. Federico, A. Paveri, M. Martelli, A. Lopez Guillermo, E. Oldani, F. Rossigni, E. Zucca, A. Conconi, T. Barbui, F. Cavalli.
Low rate of CNS recurrence in a cohort of 309 primary extranodal head and neck diffuse large B-cell lymphoma (HB-DLBCL) (IELSG 23).
9th International Conference on Malignant Lymphoma – Lugano, Switzerland 8-11 June 2005.
Abstract 414: Annals of Oncology Volume 16, 2005 Supplement 5
L. Arcaini, S. Burcheri, F. Passamonti, E. Brusamolino, M. Paulli, E. Boveri, A. Rossi, A. Pulsoni, M. C. Cox, L. Orsucci, A. Fabbri, M. Frezzato, M. Voso, F. Zaja, F. Molteni, M. Lazzarino.
HCV infection and solid neoplasms in non-gastric marginal zone B-cell lymphoma of MALT.
9th International Conference on Malignant Lymphoma – Lugano, Switzerland 8-11 June 2005.
Abstract 429: Annals of Oncology Volume 16, 2005 Supplement 5
Broglia C, Gobbi P, Levis A, Sacchi S, Chisesi T, Valentino F, Iannitto E, Brugiatelli M, Baldini L, Federico M.
MOPPEBVCAD chemotherapy with limited radiotherapy in advanced Hodgkin’s lymphoma: 10-year results.
9th International Conference on Malignant Lymphoma – Lugano, Switzerland 8-11 June 2005.
Abstract 543: Annals of Oncology Volume 16, 2005 Supplement 5
Gallamini A, Tavera S, Biggi A, Torchio PF, Rigacci L, Castagnoli A, Merli F, Versari A, Luminari S, Sancetta R, Gregianin M, Vitolo U, Pelosi E, Iannitto E, Bosi A, Levis A.
Predictive value of 18FDG-PET scan performed after two courses of ABVD on treatment outcome in advanced-stage Hodgkin’s disease.
40th Congress of the Italian Society of Hematology – Bergamo, July 3-6, 2005.
Abstract C007: Haematologica vol. 90 [suppl. n. 3]: July 2005
Cortellazzo S, Rossi A, Federico M, Peveri A, Martelli M, Lopez Guillermo A, Oldani E, Rossini F, Zucca E, Conconi AR, Busetto M, Gaidano G, Barbui T, Cavalli F, on behalf of IELSG and IIL.
The modified international prognostic index predicts the clinical outcome of 416 patients with primary extranodal head and neck non-Hodgkin’s Lymphoma.
40th Congress of the Italian Society of Hematology – Bergamo, July 3-6, 2005.
Abstract C011: Haematologica vol. 90 [suppl. n. 3]: July 2005
Gobbi P, Broglia C, Valentino F, Levis A, Federico M, Chisesi T, Iannitto E, Pavone E, Brugiatelli M, Baldini L (per conto del Gruppo Italiano Studio Linfomi e dell’Intergruppo Italiano Linfomi).
10-year results with MOPPEBVCAD chemotherapy and optional, limited radiotherapy in advanced Hodgkin Lymphoma.
40th Congress of the Italian Society of Hematology – Bergamo, July 3-6, 2005.
Abstract P181: Haematologica vol. 90 [suppl. n. 3]: July 2005
Rigacci L, Merli F, Castagnoli A, Versari A, Nassi L, Capodanno I, Chisesi T, Gallamini A, Biggi A, Vitolo U, Tavera S, Sancetta R, Pregno P, Salvi F, Scattolin AM, Dei Rossi F, Pelosi E, Levis A, Bosi A on behalf of Intergruppo Italiano Linfomi.
Comparison between 2-deoxy-2-[18] fluoro-D-glucose positron emission and computer tomography for staging of patients with Hodgkin’s Lymphoma.
40th Congress of the Italian Society of Hematology – Bergamo, July 3-6, 2005.
Abstract P187: Haematologica vol. 90 [suppl. n. 3]: July 2005
Pagano L, Gallamini A, Trapè G, Mattei D, Todeschini G, Spadea A, Cinieri S, Iannitto E, Martelli M, Nosari A, Petti MC, Falcucci P, Di Bona E, Storti S, Valentini CG, Montanaro M, Larocca LM, Leone, G for the IIL (Intergruppo Italiano Linfomi).
T/NK “Nasal Type” Lymphomas: an Italian cooperative survey.
40th Congress of the Italian Society of Hematology – Bergamo, July 3-6, 2005.
Abstract P223: Haematologica vol. 90 [suppl. n. 3]: July 2005
Boccomini C, Ladetto M, Pogliani E, Rota Scalabrini D, Tarella C, Castellino C, Aglietta M, Astolfi M, Carpaneto A, Corradini P, Darbesio A, De Crescenzo A, Levis A, Liberati AM, Morandi S, Orsucci L, Pregno P, Rigacci L, Rossini F, Tonso A, Gallo E, Vitolo U.
Sequential brief chemo-immunotherapy FND + Rituximab as first line treatment for elderly patients with follicular lymphoma is able to induce clinical and molecular remission with prolonged failure-free survival.
40th Congress of the Italian Society of Hematology – Bergamo, July 3-6, 2005.
Abstract P519: Haematologica vol. 90 [suppl. n. 3]: July 2005
Merli F, Luminari S, Botto B, Baldini L, Rossi G, Stelitano C, Mazza P, Liberati M, Ilariucci F, Broglia C, Levis A.
Interim results of a randomised study by Intergruppo Italiano Linfomio (IIL) comparing R-CHOP and R-MINI-CEOP in a population of elderly patients (over 65) with diffuse large B cell lymphoma (DLCL).
40th Congress of the Italian Society of Hematology – Bergamo, July 3-6, 2005.
Abstract P522: Haematologica vol. 90 [suppl. n. 3]: July 2005
S Cortellazzo, A Rossi, M Federico, A Peveri, S Magrini, M Martelli, A Lopez Guillermo, E Oldani, A Rambaldi, F Rossini, E M Pogliani, E Zucca, A Conconi, M Busetto, G Gaidano, T Barbui and F Cavalli.
The stage-modified IPI (MIPI), histology and a combined treatment influence the clinical outcome of 401 patients with primary extranodal head and necj B-cell lymphoma (PHNBCL) (IELSG 23).
American Society of Hematology 47th Annual Meeting and Exposion, December 10-13, 2005, Atlanta.
Abstract #927 appears in Blood, Volume 108, issue 11, November 16, 2005
Rigacci L, Merli F, Castagnoli A, Versari A, Nassi L, Capodanno I, Chisesi T, Gallamini A, Biggi A, Vitolo U, Tavera S, Sancetta R, Pregno P, Salvi F, Pelosi E, Levis A, Bosi A Hematology, Azienda Ospedaliera Universitaria Careggi on behalf of Intergruppo Italiano Linfomi, Florence Italy.
Comparision between 2-deoxy-2-[18F] fluroo-D-Glucose Positron Emission (FDG-PET) and computed tomography (CT) for staging of patients with Hodgkin’s Lymphoma (HL).
session type: poster 133-I
American Society of Hematology 47th Annual Meeting and Exposion, December 10-13, 2005, Atlanta.
Abstract #975 appears in Blood, Volume 108, issue 11, November 16, 2005
Arcaini L, Brucheri S, Rossi A, Passamonti F, Colombo N, Paulli M, Boveri E, Brusamolino E, Moleni A, Pulsoni A, Cox M C, Orsucci L, Fabbri A, Frezzato M, Voso M T, Zaja F, Pascutto C, Morra E, Cortellazzo S, Lazzarino M Division of Hematology and Departement of Patology, IRCCS Policlinico S Matteo, University of Pavia, Centers of the IIL (Italian Lymphoma Intergroup).
HCV Infection in Nongastric Marginal Zone B-Cell Lymphoma of MALT.
session type: poster 145-I
American Society of Hematology 47th Annual Meeting and Exposion, December 10-13, 2005, Atlanta.
Abstract #987 appears in Blood, Volume 108, issue 11, November 16, 2005
P P Piccaluga, P Went, C Agostinelli, A Gallamini, S Ascani, E Sabattini, F Bacci, F Brunangelo, T Motta, M Paulli, T Artusi, P L Zinzani, M Baccarini, A Pileri on behalf of the Intergruppo Italiano Linfomi.
Marker Expression in peripheral T-Cell Lymphoma unspecified: proposal of a clinical pathologic prognostic score.
American Society of Hematology 47th Annual Meeting and Exposion, December 10-13, 2005, Atlanta.
Abstract #2819 appears in Blood, Volume 108, issue 11, November 16, 2005
F Merli, U Vitolo, S Luminari M Patrizio, C Stelitano, G Rossi, L Baldini, F Ilariucci and A Levis.
R-CHOP vs R-mini-CEOP in Elderly Patients with Diffuse Large Cell Lymphoma: an interim report from Intergruppo Italiano Linfomi (IIL).
American Society of Hematology 47th Annual Meeting and Exposion, December 10-13, 2005, Atlanta.
Abstract #4729 appears in Blood, Volume 108, issue 11, November 16, 2005
A Gallamini, D Mattei, C Stelitano, M Martelli, S Cortellazzo, G Todeschini, F Zaja, L Rigacci, L Devizzi, E Brusamolino, M Brugiatelli, M Federico on behalf of the Intergruppo Italiano Linfomi.
ASCT is not superior to conventional-dose, anthracyclin-based chemotherapy in peripheral T-cell lymphoma.
30th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) – Barcelona, Spain, March 28-31, 2004.
Bone Marrow Transplantation – Volume 33, Supplement 1, 2004
V Pavone, F Gaudio, U Vitolo, G Console, A Guarini, T Perrone, A Giordano, R De Francesco, G Loseto, P Iacopino, E Gallo, V Liso.
Poor mobilisation status: an indipendent prognostic factor to predict outcome in patients with malignant lymphomas.
30th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) – Barcelona, Spain, March 28-31, 2004.
Bone Marrow Transplantation – Volume 33, Supplement 1, 2004
M Federico, A Levis, S Luminari, T Chisesi, L Marcheselli, M Goldaniga, U Vitolo, S Neri, M Brugiatelli, P G Gobbi.
ABVD vs STANFORD V (SV) vs MOPP-EBV-CAD (MEC) in Advanced Hodgkin’s Lymphoma. Final Results of the IIL9601 Randomized Trial.
40th Annual Meeting – June 5-8, 2004 – Ernest N. Morial Convention Center New Orleans.
Abstract 6506: Annual Meeting Proceedings – AMERICAN SOCIETY of CLINICAL ONCOLOGY – Volume 22, Supplement 14s
U. Vitolo, C. Boccomini, M. Ladetto, E. Pogliani, D. Rota Scalabrini, C. Tarella, C. Castellino, M. Aglietta, M. Astolfi, B. Botto, A. Carpaneto, P. Corradini, A. Darbesio, A. De Crescenzo, A. Levis, A. M. Liberati, S. Morandi, L. Orsucci, L. Rigacci, F. Rossini, A. Tonso, E. Gallo. High clinical and molecular response after brief chemo-immunotherapy FND + Rituximab in elderly patients with de novo advanced stage follicular lymphoma (FL).
9th Congress of the European Hematology Association – Geneva Palexpo, Switzerland, 10 – 13 june 2004.
Abstract 018: The Hematology Journal – Volume 5, Supplement EHA, 2004.
M Federico, A Levis, S Luminari, T Chisesi, L Marcheselli, M Goldaniga, U Vitolo, S Neri, M Brugiatelli, P G Gobbi.
ABVD vs STANFORD V (SV) vs MOPP-EBV-CAD (MEC) in Advanced Hodgkin’s Lymphoma. Final Results of the IIL9601 Randomized Trial.
6th International Symposium on Hodgkin’s Lymphoma – Cologne, Germany 18-21 September 2004.
Abstract A10: Haematology volume 73 – Supplement 65 – September 2004.
A. Gallamini, E. Raviolo, F. Merli, L. Rigacci, L. Nassi, S. Santini, A. Biggi, A. Castagnoli and A. Levis.
Predictive value of positron emission tomography (PET) performed after two cycles of standard chemotherapy on treatment outcome in Hodgkin disease.
6th International Symposium on Hodgkin’s Lymphoma – Cologne, Germany 18-21 September 2004.
Abstract D04: Haematology volume 73 – Supplement 65 – September 2004.
A. M. Liberati, P. Cerroni, R. Hijazi, F. Di Costanzo, A. Levis, M. Spina, E. Pavone, P. L. Zinzani, E. Angelucci, D. Rota Scalabrini, A. Gallamini, L. Rigacci, E. Rossi, G. Martinelli, S. Viviani, S. Sacchi, M. Federico, M. C. Bertoncelli, G. Saglio, E. Iannitto, E. Brusamolino, P. Gobbi, M. Lombardo, L. Cavanna, M. Petrini, C. Stelitano, F. Merli, E. Cavalieri, A. Novarino, U. Vitolo, P. Gavarotti, T. Chisesi, R. Zanotti and M. Frezzato.
Italian Lymphoma Intergroup
Features of relapsed disease in lymphocyte predominant Hodgkin’s disease patients.
6th International Symposium on Hodgkin’s Lymphoma – Cologne, Germany 18-21 September 2004.
Abstract WL01: Haematology volume 73 – Supplement 65 – September 2004.
A. M. Liberati, P. Cerroni, R. Hijazi, F. Di Costanzo, A. Levis, M. Spina, E. Pavone, P. L. Zinzani, E. Angelucci, D. Rota Scalabrini, A. Gallamini, L. Rigacci, E. Rossi, G. Martinelli, S. Viviani, S. Sacchi, M. Federico, M. C. Bertoncelli, G. Saglio, E. Iannitto, E. Brusamolino, P. Gobbi, M. Lombardo, L. Cavanna, M. Petrini, C. Stelitano, F. Merli, E. Cavalieri, A. Novarino, U. Vitolo, P. Gavarotti, T. Chisesi, R. Zanotti and M. Frezzato.
Italian Lymphoma Intergroup
Natural history of lymphocyte predominant Hodgkin’s lymphoma.
6th International Symposium on Hodgkin’s Lymphoma – Cologne, Germany 18-21 September 2004.
Abstract WL02: Haematology volume 73 – Supplement 65 – September 2004.
A. M. Liberati, P. Cerroni, R. Hijazi, F. Di Costanzo, A. Levis, M. Spina, E. Pavone, P. L. Zinzani, E. Angelucci, D. Rota Scalabrini, A. Gallamini, L. Rigacci, E. Rossi, G. Martinelli, S. Viviani, S. Sacchi, M. Federico, M. C. Bertoncelli, G. Saglio, E. Iannitto, E. Brusamolino, P. Gobbi, M. Lombardo, L. Cavanna, M. Petrini, C. Stelitano, F. Merli, E. Cavalieri, A. Novarino, U. Vitolo, P. Gavarotti, T. Chisesi, R. Zanotti and M. Frezzato.
Italian Lymphoma Intergroup
Disease and non-disease related mortality in lymphocyte predominant Hodgkin’s disease patients.
6th International Symposium on Hodgkin’s Lymphoma – Cologne, Germany 18-21 September 2004.
Abstract WL03: Haematology volume 73 – Supplement 65 – September 2004.
U. Vitolo, C. Boccomini, M. Ladetto, E. Pogliani, D. Rota Scalabrini, C. Tarella, C. Castellino, M. Aglietta, M. Astolfi, A. Carpaneto, P. Corradini, A. Darbesio, A. De Crescenzo, A. Levis, A. M. Liberati, S. Morandi, L. Orsucci, P. Pregno, L. Rigacci, F. Rossini, A. Tonso, E. Gallo. ON the behalf of Intergruppo Ialiano Linfomi (IIL).
Seuqential breif chemo-immunotherapy FND+Rituximab in elderly patients with advanced stage follicular lymphoma (FL): high clinical and molecular remission rate associated with a prolonged failure-free survival.
American Society of Hematology 46th Annual Meeting and Exposion, December 4-7, 2004, San Diego, CA.
Abstract #1320 appears in Blood, Volume 104, issue 11, November 16, 2004.
S. Cortellazzo, S. Luminari, M. Bellei, M. Martelli, U. Vitolo, L. Rigacci, A. Ambrosetti, E. Pogliani, T. Chisesi, G. Rossi, A. Rossi, A. Rambaldi, T. Barbui, M. Brugiatelli, M. Federico.
A predictive model for limited stage diffuse large B-cell lymphoma (DLBCL): a retrospective analysis of 1,252 cases performed by the Intergruppo Italiano Linfomi (IIL).
American Society of Hematology 46th Annual Meeting and Exposion, December 4-7, 2004, San Diego, CA.
Abstract #3261 appears in Blood, Volume 104, issue 11, November 16, 2004.
V. Pavone, F. Gaudio, A. Guarini, T. Perrone, P. Iacopino, U. Vitolo, G. Console, E. Gallo, P. Curci, A. Giordano, R. De Francesco, G. Loseto, V. Liso.
Predictive factors of poor stem cells mobilization in patients with malignant lymphomas: a multicenter analysis.
8th Congress of the European Hematology (EHA) Lyon, France, 12-15 June 2003.
Abstract #0018 (EHA Meeting Abstracts, 2003).
M. Ladetto, I. Ricca, F. Benedetti, M. Liberati, U. Vitolo, M. Musso, A. Gallamini, V. Callea, V. Pavone, C. Almici, F. Di Raimondo, C. De Sousa, G. Fioritoni, I. Majolino, A. Olivieri, C. Patti, E. Pogliani, M. Astolfi, M. Boccadoro, A. M. Gianni, P. Corradini, C. Tarella on behalf of GITMO.
Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with rituximab in poor-risk follicular lymphoma: early evaluation on treatment feasibility and response rate.
29th Annual Meeting of the European Group for Blood and Marrow Trasnsplantation (EMBT), Istanbul, Turkey, 20-23 July 2003.
Abstract 0134: Bone Marrow Trasnsplantation – Volume 31, Supplement 1, 2003.
L. Baldini, S. Luminari, U. Vitolo, M. Federico, A. Ambrosetti, R. Calori, S. Capalbo, A. Pulsoni, S. Cortellazzo, M. Goldaniga, L. Cro, M. Bellei, T. Barbui, M. Brugiatelli.
Clinical and prognostic features of CD5 negative mature B cell leukemias: a retrospective study on 139 patients performed by Intergruppo Italiano Linfomi.
XXXIX Congress of The Italian Society of Hematology – Rome, October 26-29, 2003.
Abstract P0008: Haematologica vol 88 [suppl. n. 15]: october 2003.
S. Cortellazzo, S. Luminari, M. Bellei, M. Martelli, U. Vitolo, L. Rigacci, A. Ambrosetti, A. Rossi, T. Barbui, M. Federico.
Clinical and prognostic features of patients with limited stage diffuse large B-cell lymphoma: a retrospective study performed by the Italian Lymphoma Intergroup.
XXXIX Congress of The Italian Society of Hematology – Rome, October 26-29, 2003.
Abstract P0027: Haematologica vol 88 [suppl. n. 15]: october 2003.
U. Vitolo, C. Boccomini, M. Ladetto, E. Pogliani, D. Rota Scalabrini, C. Tarella, C. Castellino, M. Aglietta, M. Astolfi, B. Botto, A. Carpaneto, P. Corradini, A. Darbesio, A. De Crescenzo, A. Levis, A. M. Liberati, S. Morandi, L. Orsucci, L. Rigacci, F. Rossini, A. Tonso, E. Gallo.
A brief course of chemo-immunotherapy FND + RITUXIMAB is effective to induce a high clinical and molecular response in elderly patients with advanced stage follicular lymphomas ad diagnosis.
XXXIX Congress of The Italian Society of Hematology – Rome, October 26-29, 2003.
Abstract P0183: Haematologica vol 88 [suppl. n. 15]: october 2003.
U.Vitolo, S. Luminari, L. Baldini, M. Federico, A. Ambrosetti, F. Angrilli, M. Colombi, S. Cortellazzo, L. Orsucci, E. Pogliani, A. Pulsoni, L. Rigacci, D. Rota Scalabrini, C. Stelitano, N. Villivà, P. L. Zinzani, M. Brugiatelli.
Clinical and prognostic features of indolent B-cell nonfollicular lymphoma: a retrospective study on 373 patients performed by Intergruppo Italiano Linfomi.
XXXIX Congress of The Italian Society of Hematology – Rome, October 26-29, 2003.
Abstract P0202: Haematologica vol 88 [suppl. n. 15]: october 2003.
F. Morabito, C. Stelitano, A. Gallamini, M. Federico, M. Brugiatelli, M. Bellei, V. Callea, F. Caracciolo, A. M. Carella, L. Devizzi, F. Ilariucci, M. Lombardo, S. Luminari, M. Martelli, G. Santini, U. Vitolo per l’Intergruppo Italiano Linfomi e Gruppo Italiano Studio Linfomi.
Clinical relevance of immunophenotype in a retrospective study of peripheral T-cell lymphoma unspecified and diffuse large B-cell lymphoma: the experience of the Intergruppo Italiano Linfomi on 752 cases.
XXXIX Congress of The Italian Society of Hematology – Rome, October 26-29, 2003.
Abstract PU073: Haematologica vol 88 [suppl. n. 15]: october 2003.
L. Rigacci, L. Nassi, A. Biggi, A. Castagnoli, E. Raviolo, A. Levis, A. Gallamini.
Hodgkin’s disease: predictive value of positron emission tomography performed after two cycles of chemotherapy on treatment. A preliminary report.
XXXIX Congress of The Italian Society of Hematology – Rome, October 26-29, 2003.
Abstract PU080: Haematologica vol 88 [suppl. n. 15]: october 2003.
P. Pregno, B. Botto, A. M. Liberati, E. Pavone, F. Salvi, M. Badone, C. Boccomini, R. Freilone, P. Degli Angeli, E. Larizza, A. Levis, L. Orsucci, E. Gallo, U. Vitolo on the behalf of the Intergruppo Italiano Linfomi.
An “age adjusted” high dose chemotherapy (HDC) with ASCT is will tolerated and effective in elderly patients with aggressive Non Hodgkin’s Lymphoma (NHL).
XXXIX Congress of The Italian Society of Hematology – Rome, October 26-29, 2003.
Abstract PU189: Haematologica vol 88 [suppl. n. 15]: october 2003.
S. Cortellazzo, S. Luminari, M. Bellei, M. Martelli, U. Vitolo, L. Rigacci, A. Ambrosetti, A. Rossi, T. Barbui, M. Brugiatelli, M. Federico (Intr. by A. Rambaldi).
The prognosis of limited stage diffuse large B-cell lymphoma (DLBCL): a retrospective analysis of 950 cases performed by the Intergruppo Italiano Linfomi.
American Society of Hematology 45th Annual Meeting and Exposion, December 6-9, 2003, San Diego, CA.
Abstract #1422 appears in Blood, Volume 102, issue 11, November 16, 2003.
U. Vitolo, C. Boccomini, M. Ladetto, E. Pogliani, D. R. Scalabrini, C. Tarella, C. Castellino, M. Aglietta, M. Astolfi, B. Botto, A. Capaneto, P. Corradini, A. Darbesio, A. de Crescenzo, A. Levis, A. M. Liberati, S. Morandi, L. Orsucci, L. Rigacci, F. Rossini, A. Tonso, E. Gallo.
A brief course of chemo-immunotherapy FND+Rituximab is effective to induce a high clinical and molecular response in elderly patients with advanced stage follicular lymphoma (FL) at diagnosis.
American Society of Hematology 45th Annual Meeting and Exposion, December 6-9, 2003, San Diego, CA.
Abstract #1452 appears in Blood, Volume 102, issue 11, November 16, 2003.
P. Pregno, B. Botto, A. M. Liberati, E. Pavone, F. Salvi, A. Tonso, C. Boccomini, R. Freilone, P. Degli Angeli, E. Larizza, A. Levis, L. Orsucci, E. Gallo, U. Vitolo.
Aggressive Non-Hodgkin’s Lymphoma (NHL) in elderly patients: an “age-adjusted” high dose chemotherapy (HDC) with ASCT is feasible and effective.
American Society of Hematology 45th Annual Meeting and Exposion, December 6-9, 2003, San Diego, CA.
Abstract #5657 appears in Blood, Volume 102, issue 11, November 16, 2003.
S. A. Pileri, G. Gaidano, P. L. Zinzani, B. Falini, P. Gaulard, E. Zucca, F. Pieri, C. Valli, E. Berra, E. Sabattini, S. Ascani, M. Piccioli, P. Johonson, R. Giardini, E. Pescarmona, D. Novero, T. Marafioti, M. A. Alonso, F. Cavalli.
Mediastinial slerosing large B-cell lymphoma. An overview based on results of a pathologic trial supported by the International Extranodal Lymphoma Study Group (IELSG).
8th International Conference on Malignant Lymphoma. 12-15 June, 2002: Lugano, Switzerland.
Abstract 067: Annals of Oncology – Volume 13, 2002 Supplement 2.
A. Levis, P. G. Gobbi, T. Chisesi, M. Federico, F. Bertolini, P. Gavarotti, T. Guglielmelli, F. Ilariucci, G. Lambertenghi Deliliers, M. Liberati, M. Lombardo, D. Vallisa, G. Santini, U. Vitolo, M. Brugiatelli. ABVD vs. STANFORD V vs. MOPP-EBV-CAD in Advanced Hodgkin’s Lymphoma. Results of a Randomized Trial.
8th International Conference on Malignant Lymphoma. 12-15 June, 2002: Lugano, Switzerland.
Abstract 071: Annals of Oncology – Volume 13, 2002 Supplement 2.
U. Vitolo, A. M. Liberati, G. Lamberteghi Deliliers, R. Calvi, L. Baldini, M. Bertini, C. Boccomini, M. Brugiatelli, M. G. Cabras, N. Di Renzo, M. Federico, R. Freilone, A. Levis, G. Parvis, E. Pavone, P. Pregno, M. Petrini, M. Sborgia, G. Todeschini, M. Trottini and E. Gallo.
High dose chemotherapy (HDS) with autologus stem cell trasplantation (ASCT) vs intensified chemotherapy megaCEOP in high risk diffuse large cell lymphoma (DLCL): an update of a multicenter randomized trial by italian lymphoma intergroup (ILI).
8th International Conference on Malignant Lymphoma. 12-15 June, 2002: Lugano, Switzerland.
Abstract 086: Annals of Oncology – Volume 13, 2002 Supplement 2.
A. Gallamini, C. Stelitano, M. Federico, M. Bellei, D. Mattei, F. Morabito, U. Vitolo, M. Martelli, F. Zaja, L. Devizzi, L. Rigacci, G. Santini, S. Cortellazzo, P. L. Zinzani, G. Todeschini.
Peripheral T-cell lymphoma, unspecified (PTCL-U): a prognostic: a prognostic model based on a retrospective analysis of 383 cases of the Intergruppo Italiani Linfomi (IIL).
8th International Conference on Malignant Lymphoma. 12-15 June, 2002: Lugano, Switzerland.
Abstract 102: Annals of Oncology – Volume 13, 2002 Supplement 2.
M. Brugiatelli, U. Vitolo, M. Federico, S. Luminari, C. Stelitano, M. Colombi, F. Angrilli, A. Pulsoni, N. Villivà, P. L. Zinzani, S. Cortellazzo, L. Rigacci, L. Orsucci, A. Ambrosetti.
Indolent non follicular lymphoma: retrospective study of the italian lymphoma intergroup on 580 cases.
8th International Conference on Malignant Lymphoma. 12-15 June, 2002: Lugano, Switzerland.
Abstract 175: Annals of Oncology – Volume 13, 2002 Supplement 2.
L. Rigacci, M. Federico, M. Martelli, P. L. Zinzani, L. Cavanna, F. Merli, R. Alterini, A. Carpaneto, V. Carrai, A. Perrotti, M. Tani, A. M. Liberati, U. Vitolo, V. Pavone, A. Cuneo, T. Chisesi,, M. Brugiatelli.
Antracyclin containing regimens for the treatment of follicular lymphoma: a retrospective analysis of the Intergruppo Italiano Linfomi (IIL).
8th International Conference on Malignant Lymphoma. 12-15 June, 2002: Lugano, Switzerland.
Abstract 189: Annals of Oncology – Volume 13, 2002 Supplement 2.
M. Martelli, F. Gomez, E. Conde and C. Guglielmi on behalf of I.I.L., GITMO; GELTAMO, PARMA study.
Prognostic evalutation in adults with diffuse large B-cell lymphoma treated with autologus stem cell transplant (ASCT) at first sensitive relapse.
8th International Conference on Malignant Lymphoma. 12-15 June, 2002: Lugano, Switzerland.
Abstract 234: Annals of Oncology – Volume 13, 2002 Supplement 2.
M. Bertini, F. Merli, R. Mozzana, B. Botto, M. Cabras, M. Liberati, R. Bertè, L. Baldini, V. Fregoni, A. J. Ferreri, M. Nicolini, A. De Paoli, P. Pregno and E. Gallo on the behalf of Intergruppo Italiano Linfomi (I.I.L.)P-VEBEC vs Mini-CEOP: a randomized study to compare the effetiveness and the quality of life (QoL) of two different schedules devised for elderly patients affected by diffuse large cell lymphoma (DLCL).
8th International Conference on Malignant Lymphoma. 12-15 June, 2002: Lugano, Switzerland.
Abstract 237: Annals of Oncology – Volume 13, 2002 Supplement 2.
V. Pavone, A. Levis, P. G. Gobbi, M. Federico, C. Broglia, M. Colombi, L. Ferrara, E. Gallo, E. Gallo, E. Iannitto, G. Lambertenghi Deliliers, V. Liso, G. Pilo, D. Rota Scalabrini.
ABVD plus RADIOTHERAPY vs. EVE plus RADIOTHERAPY in Unfovorable Stage IA and IIA Hodgkin’s Lymphoma: Preliminary Results of a Randomized Study.
8th International Conference on Malignant Lymphoma. 12-15 June, 2002: Lugano, Switzerland.
Abstract 405: Annals of Oncology – Volume 13, 2002 Supplement 2.
F. Merli, M. Bertini, S. Sacchi, A. M. Liberati, F. Malorgio, U. Vitolo, C. Stelitano, R. Freilone, G. Polimeno, M. Galliano, E, Gallo and L. Gugliotta.
A Pilot Study with an oral chemotherapy Regimen (CIEP) in The Treatment of Diffuse Large Cell Lymphoma (DLCL) in elderly patients: an interim report from Italia Lymphoma Intergroup (ILI).
8th International Conference on Malignant Lymphoma. 12-15 June, 2002: Lugano, Switzerland.
Abstract 554: Annals of Oncology – Volume 13, 2002 Supplement 2.
U. Vitolo, L. Baldini, M. Federico, S. Luminari, C. Stelitano, M. Colombi, F. Angrilli, A. Pulsoni, D. Rota Scalabrini, N. Villivà, P. L. Zinzani, S. Cortellazzo, L. Rigacci, L. Orsucci, A. Ambrosetti, G. Rossi, M. Brugiatelli.
Clinical and prognostic features of indolent non-follicular lymphoma: a retrospective study on 425 patients performed by Italian Lymphoma Intergroup.
American Society of Hematology 44th Annual Meeting and Exposion, December 6-10, 2002, Philadelphia, Pennsylvania
Abstract #4643 (ASH Meeting Abstracts, 2002).
F. Merli, M. Bertini, S. Luminari, B. Botto, G. Tarantini, R. Freilone, R. Bertè, A. M. Liberati, F. Malorgio, E. Gallo, L. Gugliotta.
CIEP: an oral chemotherapy regimen devised for diffuse large cell lymphoma (DLCL) in elderly patients: an interim report from italian lymphoma intergoup (IIL).
American Society of Hematology 44th Annual Meeting and Exposion, December 6-10, 2002, Philadelphia, Pennsylvania
Abstract #4725 (ASH Meeting Abstracts, 2002).
V. Pavone, P. G. Gobbi, F. Adamo, L. Baldini, M. Brugiatelli, M. Federico, A. Gallamini, P. Gavarotti, M. Liberati, F. Merli, D. Pietrasanta, U. Vitolo, A. Levis.
ABVD plus radiotherapy vs EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin’s disease: preliminary results of an Intalian Intergroup randomized study.
Fifth International Symposium on Hodgkin’s Lymphoma, 22-25 september 2001, Köln, Germany.
Abstract P-093: Leukemia & Lymphoma, ISSN 1042-8194 LELYEA 42 1-114 (2001) Supplement 2 to volume 2.
T. Chisesi, P. Gobbi, A. Levis, G. Lambertenghi, M. Federico, M. Brugiatelli.
ABVD, Stanford V and MOPP-ABV-CAD in unfavourable Hodgkin’s disease (HD), results of a randomized trial.
Fifth International Symposium on Hodgkin’s Lymphoma, 22-25 september 2001, Köln, Germany.
Abstract P-108: Leukemia & Lymphoma, ISSN 1042-8194 LELYEA 42 1-114 (2001) Supplement 2 to volume 2.
A. Levis, A. P. Anselmo, A. Ambrosetti, M. Bertini, V. Pavone, M. Liberati, A. Gallamini, P. Gavarotti, E. Cavalieri, D. Pietrasanta, E. D’Andrea, F. Salvi, U. Vitolo, G. Broccia, E. Gallo.
VEPEMB chemotherapy in elderly Hodgkin’s disease patients.
Fifth International Symposium on Hodgkin’s Lymphoma, 22-25 september 2001, Köln, Germany.
Abstract P-233: Leukemia & Lymphoma, ISSN 1042-8194 LELYEA 42 1-114 (2001) Supplement 2 to volume 2.
L. Rigacci, M. Martelli, M. Federico, P. L. Zinzani, L. Baldini, U. Vitolo, M. Brugiatelli, T. Chisesi, G. Bellesi, L. Resegotti.
Antrhracycline-containing regimens for the treatment of follicular lymphoma: a retrospective analysis of the Intergruppo Italiano Linfomi.
38th Congress of the Italian Society of Hematology – Florence, October 7-10, 2001.
Abstract C0042: Haematologica vol. 86(suppl. to n. 10): october 2001.
U. Vitolo, A. M. Liberati, G. Lambertenghi Delilers, M. Bertini, R. Calvi, R. Freilone, L. Baldini, M. Brugiatelli, N. Di Renzo, M. Federico, G. Cabras, G. Parvis, E. Pavone, M. Petrini, F. Salvi, M. Sborgia, G. Todeschini, E. Gallo.
High dose chemotherapy with autologus transplantation vs intensified chemotherapy megaCEOP in poor prognosis diffuse large cell lymphoma: comparable remission rate and toxicity in a multicenter randomized trial by italian lymphoma intergroup.
38th Congress of the Italian Society of Hematology – Florence, October 7-10, 2001.
Abstract C0052: Haematologica vol. 86(suppl. to n. 10): october 2001.
C. Broglia, P. G. Gobbi, M. Brugiatelli, C. Stelitano, F. Merli, L. Baldini, E. Iannitto, G. Polimeno.
Early-stage, favorable Hodgkin’s disease: very good results and minimal toxicity VBMp chemotherapy + involved field radiotherapy.
38th Congress of the Italian Society of Hematology – Florence, October 7-10, 2001.
Abstract C0057: Haematologica vol. 86(suppl. to n. 10): october 2001.
V. Pavone, P. G. Gobbi, F. Adamo, L. Baldini, M. Brugiatelli, M. Federico, E. Iannitto, P. Gavarotti, T. Guglielmelli, M. Liberati, U. Vitolo, A. Levis.
Preliminary results of the Italian Intergroup Lymphoma randomized study ABVD versus EVE in unfavourable stage I A and II A Hodgkin’s disease.
38th Congress of the Italian Society of Hematology – Florence, October 7-10, 2001.
Abstract C0064: Haematologica vol. 86(suppl. to n. 10): october 2001.
D. Pietrasanta, A. P. Anselmo, A. Ambrosetti, F. Adamo, A. Baraldi, M. Bertini, B. Botto, E. Cavalieri, R. Carpenteri, E. D’Andrea, P. Gavarotti, M. Liberati, F. Merli, V. Pavone, D. Rota Scalabrini, C. Tarella, A. Gallamini, E. Gallo, F. Mandelli, A. Levis.
Preliminary results of the VEPEMB chemotherapy regimen in elderly Hodgkin’s disease patients: an Italian Lymphoma Intergroup study.
38th Congress of the Italian Society of Hematology – Florence, October 7-10, 2001.
Abstract C0065: Haematologica vol. 86(suppl. to n. 10): october 2001.
U. Vitolo, A. M. Liberati, G. Lambertenghi Deliliers, R. Calvi, L. Baldini, M. Bertini, M. Brugitelli, M. G. Cabras, N. Di Renzo, M. Federico, R. Freilone, G. Parvis, E. Pavone, M. Petrini, F. Salvi, M. Sborgia, G. Todeschini, M. Trottini, E. Gallo.
A multicenter randomized trial by Italian Lymphoma INtergroup (ILI) comparing high dose chemotherapy (HDS) with autologus stem cell transplantation (ASCT) vs intensified chemotherapy megaCEOP in high risk diffuse large cell lymphoma (DLCL): no difference in outcome and toxicity.
American Society of Hematology 43rd Annual Meeting and Exposion, December 7-11, 2001, Orlando, FL.
Abstract #4738 (ASH Meeting Abstracts, 2001).
M. Bertini, F. Merli, D. Perego, M. G. Cabras, M. Liberati, U. Vitolo, R. Bertè, M. Colombi, A. De Paoli, V. Fregoni, E. Gallo.
Evalutation of efficacy, tolerability and QOL of P-VEBEC vs Mini-CEOP, two schedule specifically devised for elderly patients affected by diffuse large cell lymphoma: preliminary results of a randomized trial.
36th Annual Meeting of American Society of Clincal Oncology (ASCO) New Orleans, LA, 20-23 may 2000.
Abstract 154 – Proc Am Soc Clin Oncol 19, 2000.
P. L. Zinzani, M. Martelli, M. Bertini, E. Zucca.
Primary mediastinal lymphoma: a multicenter study by the IELSG.
American Society of Hematology 42nd Annual Meeting and Exposion, December 1-5, 2000, San Francisco, CA.
Abstract #0581 (ASH Meeting Abstracts, 2000).
S. Sacchi, A. Tucci, F. Merli, L. Orsucci, G. Cervetti, U. Occhini, M. Liberati, G. Tarantini, V. Callea, M. Brugiatelli, M. V. Lauta, L. Baldini, S. Luminari, F. Massimo.
Phase II study with fludarabine and cyclophosfamide plus rituximab (FC+R) in relapsed follicular lymphoma patients..
American Society of Hematology 42nd Annual Meeting and Exposion, December 1-5, 2000, San Francisco, CA.
Abstract #2246 (ASH Meeting Abstracts, 2000).
U. Vitolo, A. M. Liberati, G. Lambertenghi Deliliers, R. Calvi, M. Bertini, R. Freilone, L. Baldini, M. Brugiatelli, N. Di Renzo, M. Federico, M. G. Cabras, G. Parvis, V. Pavone, M. Petrini, F. Salvi, M. Sborgia, G. Todeschini, E. Gallo.
High dose sequential chemotherapy (HDS) with autologus transplantation (ASCT) vs intensified chemotherapy megaCEOP in poor prognosis diffuse large cell lymphoma (DLCL): comparable remission rate and toxicity in a multicenter randomized trial.
American Society of Hematology 42nd Annual Meeting and Exposion, December 1-5, 2000, San Francisco, CA.
Abstract #3424 (ASH Meeting Abstracts, 2000).
Pietrasanta D, Anselmo A. P, Baraldi A, Ambrosetti, Broccia G, Cavalieri E, D’ Andrea E, Gavarotti P, Gallamini A, Guglielmelli G, Liberati M, Pavone V, Rota Scalabrini D, Salvi F, Scassa E, Tonso A, Vitolo U, Bestini M, Gallo E, Levis A, Italian Lymphoma Inter-Group.
Preliminary results of a new chemotherapy regimen (VEPEMB) devised for Hodgkin’s disease patients.
American Society of Hematology 42nd Annual Meeting and Exposion, December 1-5, 2000, San Francisco, CA.
Abstract #4787 (ASH Meeting Abstracts, 2000).
